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ABSTRACT 
The ability of vascular cells to withstand oxidative insults is critical to vascular health. 
NAD
+
, which drives poly (ADP-ribose) polymerase (PARP) and sirtuin (SIRT) reactions, can be 
compromised and strategies for overcoming this limitation in the vasculature do not exist. This 
study determines if nicotinamide riboside (NR) delivery can augment NAD
+
 stores and fuel 
resistance to oxidative stress. I established that oxidative-stress insult on vascular cells decreased 
NAD
+
 levels, accompanied by a striking increase in nuclear PAR-chain accumulation. PARP 
inhibition abolished PAR-chain formation and preserved NAD
+
 levels, establishing PARP in 
NAD
+
 consumption in this model. NR delivery protected against cell-shrinkage and cell death 
and promoted DNA repair efficiency. PARP inhibition mimicked NR’s beneficial effects on cell-
shrinkage and viability but at the cost of DNA repair efficiency. Interestingly, the beneficial 
effects of NR on viability and DNA repair were abrogated upon SIRT1 knock-down (KD). 
SIRT6 KD was similarly implicated in NR-mediated DNA repair. Furthermore, NR delivery 
protected against oxidative-stress-induced senescence. This protection was partially lost by 
SIRT1 KD. NR delivery protects vascular cells from H2O2–induced cell death, cytoskeletal 
collapse and senescence and promotes DNA repair efficiency. This NAD
+
 fueling strategy may 
offer new opportunities for resisting oxidative-stress insults in the aging vasculature. 
 
KEYWORDS:  
NAD+, nicotinamide riboside, oxidative stress, hydrogen peroxide, PARP, sirtuin, SIRT1, 
SIRT6  
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1 – INTRODUCTION 
This introduction will begin with a review of factors that contribute to cellular aging, 
highlighting the central role oxidative stress plays in these pathways. In the next section, 
oxidative stress will then be discussed in more detail, including its involvement in disease 
progression. In the third section, cellular response pathways to oxidative stress will be introduced, 
and critically, the central role of NAD
+
 in regulating these pathways is highlighted. The final 
introductory section will focus on NAD
+
 and the potential benefits of delivery of the NAD
+
 
precursor nicotinamide riboside (NR). 
1.1 Vascular Aging: Contributing Cellular Changes  
Age is a major risk factor of cardiovascular disease.  Even in elderly individuals without 
cardiovascular disease, characteristic arterial wall changes occur including dilation, stiffening and 
intimal thickening (1). How these changes contribute to cardiovascular disease progression is not 
completely understood, but aging of vascular cells themselves is considered to be a critical factor 
(1).  Endothelial cells and vascular smooth muscle cells (SMCs) are key components of the artery 
wall. Most vessel formation will begin with an endothelial tube surrounded by pericytes. 
Subsequently, all vessels larger than capillaries will acquire a concentric SMC coat through a 
process known as arteriogenesis (2). This enables regulation of vascular tone and blood flow 
through SMCs contractile properties. During times of stress or disease, vascular SMCs are also 
involved in functions independent of their contractile properties in processes such as replication, 
migration and altering extracellular matrix proteins (3). Accordingly, aging of vascular cells can 
contribute to changes in vessel structure or function that could have critical consequences for 
blood pressure, heart attacks, and strokes (1).  Additionally, as we age the ability to repair and 
respond to stress declines through loss of angiogenic and replicative potential within 
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cardiovascular tissues. Critical to these changes are the loss in number and function of progenitor 
cells, which are undifferentiated cells with pre-determined target cell types.  
1.1.1 Endothelial Dysfunction  
Endothelial dysfunction and its interplay with vascular smooth muscle cells contribute to 
decreased vessel compliance as we age. This is mediated by decreased endothelial cell replacement 
and impaired signalling to vascular smooth muscle cells limiting vasodilation (1). One such 
vasodilator, nitric oxide (NO), is produced by nitric oxide synthase (NOS); more specific to 
endothelial cells, the enzyme isoform eNOS is present. This enzyme will use L-arginine, molecular 
oxygen and nicotinamide adenine dinucleotide phosphate (NADPH) as substrates, and in the 
presence of three cofactors, generates NO through a five electron oxidation step. An imbalance of 
cofactors can result in NOS producing superoxides instead of NO, which will alter regulation of NO 
levels but can also induce oxidative stress (4). Oxidative stress is the imbalance of reactive oxygen 
species (ROS) production and the ability of the cell to neutralize those species. Further regulation of 
NO production is enabled through binding sites for both heme and calmodulin, which are required 
for proper eNOS enzyme function (4). Expression of eNOS predominates in the endothelium of 
larger vessels and enzyme activity can be controlled at transcription, post-transcription and, 
considerably, post-translational levels (5). Basal expression levels are also subject to various 
extrinsic stimuli; specifically, eNOS can be up-regulated by stimuli including hydrogen peroxide, 
insulin and low levels of oxidized LDL (6-8).  
Proper regulation of NO production enables endothelial cells to respond to external stimuli 
and communicate the appropriate response to blood vessels to maintain homeostasis. Endothelial 
cells will produce NO, which signal for SMCs to relax. When this physiological condition is 
disrupted, it will lead to pathological conditions through either endothelial or SMC dysfunction. This 
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balance is lost during the aging process because of either decreased eNOS expression or loss of 
proper enzyme activity with increasing age (9-13). Further reducing NO production is the 
bioavailability of precursor L-arginine, this is because arginase (the final enzyme in the urea cycle) is 
upregulated in aged vasculature (14). The consequence of lower NO levels can be observed through 
vasomotor dysfunction (15, 16).   
 In addition to contributing to endothelial dysfunction, low NO production results in 
microvasculature rarefaction, through increased endothelial cell death (12). NO inhibits 
inflammation, thus decreased NO production has been linked to age-associated chronic 
inflammation. Independent of NO, loss of cells occurs during aging as a result of up-regulation of 
tumor necrosis factor alpha (TNF-α) and increased mitochondrial oxidative stress (17, 18). This is 
further aggravated by impaired angiogenesis (19) and loss of function of progenitor cells, discussed 
later.   
Another contributor to endothelial dysfunction is NAD(P)H oxidase. This plasma membrane 
protein will transfers electrons from NADPH to molecular oxygen to form extracellular superoxide 
anions, which will interfere with extracellular signalling (20-24). Coronary artery disease and stroke 
in elderly patients is linked to this aging-induced increase in oxidative stress, caused in part through 
increased NAD(P)H oxidase activity (22, 25). The superoxide anion, produced in high concentrations 
as a consequence of aging, also attenuates NO function by reacting with it to form peroxynitrite. This 
reaction reduces NO bioavailability and further, it mediates the adverse consequences of oxidative 
stress (26).  
 In summary, changes of the cellular level that alter vascular tone regulation include decreased 
production of vasodilators and instead predominance of vasoconstrictors, in parallel with vascular 
wall structural changes. Endothelial dysfunction can be broadly defined by these imbalances and 
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more specifically identified by a decline in NO.  This pathological state of the endothelium is thought 
to be a major phenotype in development of cardiovascular disease. Accelerated vascular aging and 
shorter lifespan can be modelled by defects in genes associated with endothelial dysfunction, such as 
the Klotho gene in mice (27, 28). The Klotho gene codes for a membrane protein that is associated 
with β-glucosidase and defects have been linked to chronic renal failure as well as ageing.  More 
recent evidence has supported Klotho gene’s role in inhibiting ROS production and attenuating 
inflammation (29, 30). Thus, interventions to improve vascular function in aged organisms may 
hinge on managing cellular ROS production and/or the subsequent oxidative stress response.  
1.1.2 Senescence 
Senescence is a permanent exit from the cell cycle, where cells typically take on a flattened 
and enlarged morphology.  The senescent phenotype is associated with an accumulation of negative 
cell cycle regulators including p53, p16 and p21. Additionally, using X-gal to stain for increased β-
galactosidase activity at a pH of 6.0 is a recognized biomarker of senescent cells (31). Lysosomes 
and the associated β-galactosidase accumulate in senescent cells, although it is not required for the 
acquisition of the senescent phenotype. As discussed above, decreased production of vasodilators, 
such as NO, contributes to changes in tissue structure, thereby promoting cardiovascular disease. The 
decrease in NO production is also seen in senescent vascular cells, presenting a link between 
endothelial dysfunction, senescence and vascular aging. An increase in NO by eNOS activation, on 
the other hand, can delay endothelial senescence (32). In addition, senescent cells disrupt tissue 
structure through harmful secretions including degradative enzymes, inflammatory cytokines, and 
growth factors which act to stimulate aging, thus playing a more complex role in promoting vascular 
disease phenotypes (33, 34). This senescence associated secretory phenotype further aggravates the 
system by inducing low-grade chronic inflammation within vascular tissues (35). There are two types 
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of senescence- replicative senescence and stress-induced premature senescence. Both have been 
linked to aging.  
Replicative Senescence 
Replicative senescence arises as a result of telomere shortening. Telomeres are repeating 
units of deoxyribonucleic acid (DNA) present on the ends of chromosomes. They help overcome the 
end replication problem arising due to the semiconservative nature of DNA replication by providing 
a buffer of telomeric repeats. Telomerase will add repeating segments of bases determined by an 
RNA template, and within vascular cells telomerase activity is low (36).   Telomeres will associate 
with protein to form complexes to support the stability of chromosomes and DNA replication.  Thus, 
progressive shortening of telomeres each time the cell replicates its DNA and low telomerase activity 
eventually leads to chromosomes with hanging ends that resemble damaged DNA. Following 
accumulation of p53 in response to this “damaged DNA”; downstream pathways will push towards 
the senescent phenotype.  
Within vascular endothelial cells, the lengths of telomeres were observed to be indirectly 
proportional to age (37, 38).  With each cell division telomere length is expected to decrease, 
however there is also a decrease in expression of the catalytic component of telomerase with age, 
further contributing to progressive shortening of telomeres and loss of chromosomal integrity (39). 
Shortening of telomeres in vitro was observed to contribute to endothelial dysfunction through 
changes including decreased NO synthase activity, the effects of which were discussed above (9, 40). 
In addition, stress resulting from cardiovascular disease risk factors, or shear stress from a position at 
a more dynamic region of flow, forces endothelial cells to replace damaged cells more frequently, 
also accelerating telomere shortening (38). Thus, natural aging involving gradual telomere shortening 
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combined with changes in gene expression will contribute to replicative senescence. A cells ability to 
manage and repair stress is an indirect contributing factor to replicative senescence. 
Stress-Induced Premature Senescence 
This form of senescence results from activation of cellular stress pathways, causing the cell to 
enter a senescent phenotype before reaching its age-determined replicative limit. In the case of DNA 
damage, whether by intrinsic sources such as ROS or mechanical stress (41), or by extrinsic sources 
such as radiation can induce stress-induced premature senescence. Upon DNA damage, p53 will be 
phosphorylated causing dissociation from mdm2 (an E3 ubiquitin-protein ligase) and promoting 
downstream expression of p21 or p16 which act to pause the cell cycle (42, 43).  This allows time for 
the cell to respond to damage. However, there is a carefully regulated balance. If damage is not 
repaired, accumulation of phosphorylated p53 will tip the cell to favour fates other than repair, such 
as pre-mature senescence or, if the damage is too detrimental, cell death (42). Therefore, managing 
cytotoxic stressors through carefully regulated repair pathways play a critical role in maintaining 
genome integrity, but also play a role in managing the aging process.  
Oxidative stress is a major stimulus, activating downstream pathways to initiate senescent 
phenotypes. Endothelial cells exposed to oxidative stress were pushed towards a pre-mature 
senescent phenotype, and in another study the results were supported through a contrasting 
experiment where anti-oxidants were able to delay the onset of senescence if damage was still at a 
manageable level (44-46). TNF-α and angiotensin II (ANGII) have also been implicated in the 
induction of senescence, both of which are upregulated in aging (17, 18, 21, 47). This implicates 
prolonged cytotoxic stress as a major contributor to cardiovascular disease through stress-induced 
pre-mature senescence.  
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Likely, a combination of both telomere-dependent and -independent mechanisms contributes 
to aging on a cellular level. Extrinsic factors that induce cell stress will push pathways of stress-
induced premature senescence, but also result in higher cell turnover thereby accelerating telomere 
shortening and acquisition of replicative senescent phenotype (48).  
1.1.3 Loss in Number and Function of Vascular Progenitor Cells  
Circulating within peripheral blood are angiogenic cells, some being derived from the bone-
marrow, which have been hypothesized to play a role in vascular repair (49). The role these 
progenitor cells play is still controversial, however the decreased number and function of circulating 
cells has been correlated to vascular disease, cardiovascular risk factors and age (50).  In addition to 
gradual loss of progenitor cell numbers, these cells are also subject to replicative and stress-induced 
pre-mature senescence further contributing to impaired repair response (48). Linking progenitor cell 
function to vascular aging, the number of senescent progenitor cells is correlated with human patient 
age and risk of cardiovascular disease (51, 52).  Critical to the functioning of these cells is the level 
of telomerase activity to enable effective replenishment of endothelial cell pools with sufficient 
replicative life.  Both increased oxidative stress and Ang II levels have been implicated in 
diminishing telomerase activity (53).  Both of these stressors are also known to contribute to stress-
induced pre-mature senescence in progenitor cells. 
Changes in gene expression, gradual loss of cell function, telomere shortening and loss of 
progenitor cells throughout an organism’s lifetime is expected and contributes progressively to 
the aging process. The gradual accumulation of damage, linked to oxidative stress, is the basis of 
these age-associated changes in vascular cells (Fig 1.1).  Strategies promoting more effective 
vascular cell stress response, allowing cells to resist aging, could be vital to optimizing 
healthspan. 
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Figure 1.1 Aging on a cellular level centres on oxidative stress. NO will react with ROS, 
decreasing NO bioavailability.  Decreased NO has implications on endothelial function, 
inflammation and senescence. ROS will react with DNA to form oxidative lesions that will activate 
PARP. The resulting PAR chain formation will activate NF-κβ. Accumulation of DNA damage can 
promote a senescent phenotype. Senescence-associated secretory phenotype and NF-κβ activation 
will promote inflammatory phenotype. Age-associated decrease in anti-oxidant machinery, discussed 
in section 1.3.1, will also increase ROS levels. Importantly, consequences of oxidative damage will 
feedback to further generate ROS.  
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1.2 Aging as a Gradual Accumulation of Damage 
After acknowledging that aged arteries are more susceptible to cardiovascular disease, it is 
important to understand the involvement of senescence and vascular cell dysfunction in pathological 
progression. Further, gaining an understanding of pathways that accelerate these processes is 
essential. Oxidative stress was identified as a common contributor to cellular changes in the first 
section. This section will directly consider the influence of oxidative stress in development of 
cardiovascular disease. Importantly, in vivo and in vitro models to study oxidative stress will be 
reviewed. 
1.2.1 Oxidative and Metabolic Stress 
Some level of oxidative stress is natural and occurs as ROS (including superoxide anions, 
hydroxyl radicals and hydrogen peroxide) are produced as a by-product of metabolism and in the 
production of ATP. These ROS play a role in signalling pathways for normal cell functioning and 
growth, but are also recognized as the major contributor to aging through their ability to cause 
molecular damage (54).  
ROS is generated throughout the cell for various purposes. Key contributing compartments 
include the plasma membrane, home to NAD(P)H Oxidases noted previously (55); the peroxisomes, 
which contain enzymes involved in lipid metabolism; and cytosolic enzymes, such as prostaglandin-
endoperoxide synthase, which produce lipid-based signaling molecules. It is postulated that these 
compartments are the source of about 10% generated ROS, the remaining attributed to mitochondrial 
processes (56). ATP production utilizes oxidative phosphorylation to create an electric potential 
across the mitochondrial inner membrane, generating ROS as a by-product. The controlled oxidation 
of NADH and FADH pulls electrons into a cytochrome chain, along which there are opportunities for 
electrons to react with oxygen and electron acceptors to produce superoxide anions (56). These 
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mitochondrial redox events account for the majority of cellular oxidative stress, when ROS 
overwhelms anti-oxidant systems.  
Free radicals, produced during ATP production, react rapidly or are dismutated to less 
damaging molecules by anti-oxidant machinery. On a molecular level, ROS pose a liability to cells 
through oxidized proteins altering catalytic activity through structural changes; oxidized lipids 
interfering with membrane fluidity and permeability; and oxidized DNA preventing transcription 
(57). Oxidized DNA poses a threat to genome integrity as a causative factor of DNA lesions in the 
form of single base modification, single strand breaks, double strand breaks or inter-strand crosslinks 
(58). The lesions can interfere with normal functioning, but if not repaired can also contribute to 
apoptosis, senescence or cancerous phenotypes. 
Additionally, oxidative stress has been linked to changes in mitochondrial density, function, 
number and homeostasis (57). Underlying causes of these changes include decreased expression of 
key mitochondrial proteins (decreased mRNA levels and protein synthesis), lower mitochondrial 
DNA copy number, increased nucleic acid oxidative damage and oxidative-damage-induced 
dysfunctional proteins (57).  Mitochondrial DNA and proteins are more susceptible to oxidative 
damage as a result of their proximity to the electron transport chain, generating ROS. In addition, 
mitochondrial DNA lacks the protection provided by nuclear histones.  Damage induced by 
mitochondrial oxidative stress alters function of aged mitochondria, further producing more ROS and 
less ATP (56). Impaired mitochondrial biogenesis has been reported in arteries (59) and capillaries 
(60) of aged mammals; both reports implicated increased ROS in these changes. In humans, impaired 
mitochondrial biogenesis and function has been well documented in aging populations (57). 
 Thus, there exists an optimal balance to attenuate ROS-mediated oxidative stress and promote 
somatic maintenance, but at the cost of energy-demanding growth and reproductive functions. This 
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link has been recognized for some time and the impact of caloric restriction on life-span, through 
reduced metabolic stress, has been noted (61).   
1.2.2 Inducing Oxidative Stress (H2O2) 
A common ROS is hydrogen peroxide (H2O2), which acts as both an important cellular signal 
(62, 63) and initiator of adverse downstream consequences. Free radicals generated in the 
mitochondria and dismutated to H2O2 will passively transport through the mitochondrial membrane 
into the cytoplasm; higher cytoplasmic levels of H2O2 can push endothelial cells towards a 
proinflammatory phenotype through NF-κB activation (64). Further aggravating this process, an 
imbalance of ROS (generated by NAD(P)H oxidases) and cytoplasmic H2O2 activate poly(ADP-
ribose) polymerase 1, also leading to NF-κB-dependent gene transcription.  The ensuing 
inflammation itself adds to cellular oxidative stress by cytokine-mediated activation of NAD(P)H 
oxidases. The production of H2O2 occurs more frequently in aged cells, potentially advancing 
cardiovascular pathologies (65).   
H2O2 is a powerful oxidizing agent and can alter the structure of DNA, protein and lipids. By 
definition, oxidation is the loss of electrons, reported as an increase in oxidation number of 
molecules, atoms or ions. A number of important biomarkers of DNA damage have become essential 
to the study of oxidative stress (66). One of the most common oxidative lesions is the oxidation of 
the double bond of guanine minor ring (Fig. 1.2). Although non-toxic, it can be highly mutagenic if 
not repaired through transversion reactions from G-T, as a result of binding to adenine (67, 68). 
Other direct oxidative stress-induced non-helix distorting lesions include thymine glycol, 
hydroxycytosine, formamidopyrimidines and hydroxymethylcytosine (69). In addition to damage 
directly to bases, ROS can directly cause base release or strand cleavage by attacking the glycosidic 
bond or nucleotide sugar ring, respectively (Fig. 1.3). More complex secondary reactions occur 
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following lipid peroxidation and subsequent reactions with DNA to produce helix-distorting or bulky 
lesions (66).  
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Figure 1.2 Common ROS-induced oxidative lesion resulting in DNA mutation. Oxidation of the 
double bond of guanine minor ring, leads to 8-oxoguanine, damaged guanine base. If not repaired, 
this lesion is highly mutagenic through transversion reactions from G-T, as a result of binding to 
adenine. 
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Figure 1.3 Chemical sites where ROS can directly attack sugar-phosphate backbone and/or 
DNA bases. The red asterisk indicates chemical sites that have been reported to be attacked by 
oxygen radicals. Along the sugar-phosphate back bone, oxidative damage can result in strand 
cleavage or base release.  
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Oxidative stress-induced double strand breaks are far less common than other damage types 
(70). However, they can occur indirectly when single strand breaks are formed in close proximity on 
opposite strands, and more so when repair of both lesions occurs simultaneously (71).  A common 
marker of double strand breaks is phosphorylated histone H2AX (γ-H2AX). The nucleus has been 
found to be organized into large nuclear domains known as foci. Upon certain DNA damage insults, 
γ-H2AX and DNA repair proteins will accumulate and localize to nuclear foci. Although the direct 
role of H2O2 in inducing double strand breaks is still controversial, there is evidence that this does 
occur (72). However, more recent reports have attributed oxidative stress induced γ-H2AX foci to be 
independent of double strand breaks and instead attributed them to single strand intermediates during 
DNA break repair or stalled replication forks (73).  
1.2.3 Oxidative Stress in Pathological Conditions 
  Although extensive research has focused on understanding the direct effects of oxidative 
stress and senescence, how these cellular changes result in vascular disease is less clear. Various 
recent studies have attempted to elucidate pathways that link oxidative damage to cardiovascular 
disease development. Altered mitochondrial homeostasis, impaired DNA-repair responses and 
chronic low-grade inflammation have been identified as underlying contributors to vascular disease 
development (65).  
  Within an atherosclerosis disease model, senescent markers have been used to identify 
senescent endothelial and vascular SMCs associated with atherosclerotic plaques (74, 75).   
Senescent endothelial cells were observed on the luminal surface of the blood vessels and senescent 
vascular SMCs were observed in the intima of more advanced plaques (40, 76).  Consistently, these 
cells expressed lower amounts of NO, and had increased pro-inflammatory molecules adhering to the 
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cells (76). This senescent phenotype has been attributed to DNA damage from chronic oxidative 
stress or vascular inflammation through a p21 dependent pathway (74, 75). 
Impaired mitochondrial biogenesis and function has been well documented in aging 
populations and implicated in age-associated disease and aging (57) Changes in mitochondrial 
homeostasis can be attributed to mutations of mitochondrial-specific DNA encoding 13 proteins 
required for oxidative phosphorylation (77).  Interestingly, the cause of mitochondrial DNA 
mutations is replication errors from low-fidelity polymerases, and less likely attributed to increased 
ROS or oxidative damage (78, 79). A recent report has also implicated loss of communication to 
nuclear DNA encoding additional proteins needed for proper mitochondrial function as a contributor 
(80). In aging, cells will signal for increased biogenesis of mitochondria to overcome functional 
deficits, resulting in polyclonal expansion of mitochondria with various mutations (77). The 
pathophysiology of impaired mitochondrial function is metabolic through depleted ATP, altered Ca
+
 
homeostasis and increase NAD/NADH ratios (77). In addition to impaired cellular energy 
production, these mutations impact aged tissue through increase apoptosis and potentially ROS 
production, although this is under debate (77).  
DNA-damaging cellular stressors play a central role by inducing genomic damage to 
accelerate phenotypic changes that increase risk of vascular disease. Recently, this concept was 
supported through impaired nucleotide excision DNA repair leading to an accumulation of damage 
that contributed to vessel stiffness and hypertension often associated with vascular disease (81).  
An additional pathological condition, resulting in acute damage through oxidative stress is 
sepsis, the systemic inflammation as a result of infection within the blood stream. Oxidative stress 
and associated damage, in parallel with depleted antioxidant systems, have been well reported in 
sepsis (82). Consequences of increased oxidative stress in sepsis lead to organ failure, caused by 
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inflammation through NF-κβ activation and mitochondrial dysfunction resulting in impaired energy 
production (83).  
1.2.4 Effects of ANG II on the Vasculature 
Angiotensin II (ANGII) is the downstream product of liver-produced angiotensinogen which 
is initially cleaved to form ANGI by circulating Renin and then by Angiotensin Converting Enzyme 
to form ANGII. Angiotensin converting enzyme is present in endothelial cells, and thus the bulk of 
cleavage occurs in the lung where vessel surface area is high to facilitate diffusion, but also in 
peripheral vasculature.  ANGII functions to maintain fluid volume, blood pressure and salt 
homeostasis via renin-aldosterone system- acting through its own targets and through stimulation of 
aldosterone secretion from the adrenal cortex. Together these two hormones, ANGII and aldosterone, 
will increase blood pressure and signal for changes in expression of aquaporin channels within the 
kidney to influence salt and water retention. Through these actions they will increase vascular 
resistance and blood volume which can have long-term contribution to hypertension and 
atherosclerosis (84).  
The over-activation of the renin-angiotensin system has been associated with normal aging 
(85-88). Because of this, delivery of exogenous ANGII could be used to model age-associated 
changes in vivo. ANGII has been found to down-regulate the klotho gene and protein levels, 
discussed previously as an aging model centered on endothelial dysfunction (89, 90). Reports have 
identified ANGII as a mediator of myocardial hypertrophy, sustained vascular dysfunction, 
hypertension and inflammation (91). These ANGII-mediated age-associated phenotypes have further 
been linked to pathologies including atherosclerosis and congestive heart failure (91).  
On a molecular level, ANGII will induce oxidative stress through eNOS uncoupling (92) and 
NAD(P)H oxidase activation (93, 94). As a consequence of increased NO production (95), ANGII 
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will indirectly and further cause the deleterious downstream consequences of oxidative stress through 
peryoxynitrite formation (96).  Critically, it has long been known that ANGII acts on endothelial 
progenitor cells by subjecting them to oxidative stress and lowering telomerase activity to induce a 
senescent phenotype (97). Thus, infusion or over-expression of ANGII offers an in vivo model for 
oxidative stress insult.  
Aging creates a scenario by which loss of proper enzyme function, such as eNOS introduced 
in section 1.1, leads to higher levels of endogenous ROS production, creating a vicious feedback 
cycle. Oxidative stress initiates the key cellular changes that are the foundation for loss of tissue 
function contributing to aging within an organism and onset of cardiovascular pathologies.  
Strategies that promote oxidative stress management could prevent molecular changes predictive of 
future cardiovascular disease progression.  
1.3 Managing Oxidative Stress Insults 
After reviewing the molecular basis of oxidative-stress induced aging and disease progression 
in the vasculature, H2O2 and ANGII were selected as oxidative stressors for experimental work in 
this thesis. This section will focus on the corresponding stress response pathways to promote 
vascular viability and maintain optimal cellular function. The cell has in place initial preventative 
measures to manage oxidative stress and, when free radicals exceed their capacity, repair pathways 
are initiated. Importantly, age-associated molecular changes interfere with this defence system; 
targeting these factors may enhance oxidative stress management in aged cells. 
1.3.1 Cellular Anti-Oxidant Machinery 
Cellular anti-oxidant defence systems are in place to ameliorate the damaging effects of ROS. 
Superoxide dismutase (SOD) will break down superoxide anions to H2O2. This family of proteins 
includes three isoforms present in vessel walls: a manganese-dependent, mitochondrial enzyme 
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(SOD2), a cytosolic, copper-zinc-containing enzyme (SOD1) and an extracellular, copper-zinc-
containing enzyme (SOD3) (56, 98). H2O2 itself is a reactive oxygen specie which is further broken 
down by mitochondrial ROS scavengers including catalase (to water and oxygen) (99), glutathione 
peroxidase (to water and reduced glutathione), and peroxiredoxins (100, 101).  
SOD2, present in the inner mitochondrial membrane, is the first line of defence against ROS. 
Expression levels have been reported to decline in aged mice (102). In humans, changes in anti-
oxidant enzyme expression have differed between vascular cell types (35). In endothelial progenitor 
cells, although SOD2 and catalase levels remained unchanged, glutathione peroxidase expression and 
activity levels decreased (103). In contrast, changes in human SOD2 levels were observed between 
young endothelial samples compared to sedentary aged endothelial samples (104). In another study, 
although expression levels of SOD2 were not changed, peroxynitrite-induced inactivation of the 
enzyme was observed more frequently in aortas of aged mice (24).  
The second isoform, SOD1 maintains normal endothelial vasodilation by limiting cytosolic 
superoxides; its expression and activity levels were reported to decline in aged human samples (105). 
The third SOD isoform present in the extracellular vasculature, SOD3, protects vascular cells from 
superoxide-inactivation of endothelial cellular signal NO; SOD3 expression was reported to decrease 
in aged mice (106). As ROS levels increase in aged tissues, antioxidant machinery becomes even 
more imperative to manage oxidative stress. However, as discussed here, there are reports of 
declining antioxidant expression and/or activity in aged tissues.  
1.3.2 DNA Repair Pathways 
Free radicals that are not addressed by antioxidants will damage protein, and crucially DNA. 
Within mammals there are five major DNA repair pathways: nucleotide-excision repair (NER), base-
excision repair (BER), non-homologous end joining, homologous recombination and mismatch 
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repair (58). Damage can be induced by both endogenous (repair of which is mediated mostly by BER 
(66)) and exogenous sources (repair of which is mediated mostly by NER). Both NER and BER 
involve damage that affects only one strand and generally is repaired by cutting out the damaged 
nucleoside (BER) or nucleotide (NER) and filling the gap using the complementary strand as a 
template. Bulky lesions will disrupt the helix structure and thereby restrict relevant repair enzymes 
which can no longer recognize, transcribe or replicate the DNA strand; these lesions are beyond 
BER’s scope and require NER machinery (66). When repair is incomplete, mutations can occur as 
transcription or replication proceeds to match the wrong base through minor changes to bases. The 
decreased expression of components involved in BER and downstream targets implicating reduced 
efficacy, implicate an age-associated decline in BER (107).  
DNA double-strand breaks hold high risk to impede cell function if not repaired, more so than 
damage affecting only a single strand. The repair pathways are also more complicated, as repair 
machinery must determine which ends connect together. Homologous recombination and end joining 
repair pathways overcome double strand breaks, with homologous recombination utilising the sister 
chromatid when available to ensure fidelity, and end-joining dominating in phases of the cell cycle 
when the sister chromatid is not present (108).  
1.3.3 Role of Poly (ADPribose) Polymerase Mediated DNA Repair 
Poly (ADPribose) polymerases (PARPs) family of proteins are recognized for their roles in 
base excision repair, nucleotide excision repair, and also an alternative form of non-homologous end-
joining (double-strand break repair). As such, they play a critical role in attending to genome damage 
and promoting survival from their nuclear sub localization (109, 110). PARPs will recognize 
distortion of typical DNA double helix structure and bind to DNA through a zinc finger domain 
(110). Various types of damage, including photo lesions and single strand breaks induced by ionizing 
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radiation, methylating agents or topoisomerase inhibitors, are recognized in this fashion. This 
enzyme will then initiate the repair response, utilizing NAD
+
 as a cofactor, to catalyze formation of a 
poly (ADP-ribose) chain, comprising 50-200 molecules of ADP-ribose, on nuclear proteins including 
transcription factors and histones. This provides a docking site that attracts DNA repair proteins to 
the site of damage, stabilizes repair complexes and alters enzymatic activity to promote a repair 
response. The PARP family consists of 17 members (111), with PARP1 activity accounting for 
>90% of PAR polymer generation. Thus, PARP1 is the dominant player in initiating DNA repair 
pathways mediated through NAD
+
 consumption.  
Importantly, there can be negative consequences of PARP activation. The addition of PAR 
chains to transcription factors and histones has implications for transcriptional regulation, notably on 
various inflammatory genes through NF-κB activation (112-114). One report found that PARP1-
mediated signalling promoted apoptosis resistance, through STAT3-dependent activation of NFAT 
and HIF-1α. Taken together, this suggests that PARP1 can promote prolonged survival and 
proliferation in cells sustaining chronic inflammation and consequently constitutive DNA damage 
(115).  Excessive PAR chain formation is also an initiator of PARP-mediated cell death discussed 
later. These various faces of PARP enable it to respond to oxidative stress through PAR chain 
formation, signaling for downstream repair pathways or regulating the carful balance between repair 
and cell death (Fig. 1.4). However, the adverse consequences of PAR-mediated signalling are also 
noted.  
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Figure 1.4 The balance between repair and death hinges on PARP activity. In blue, moderate 
PARP activation will catalyze PAR chain formation on PARP itself, histone and non-histone proteins 
to promote repair responses. PAR chain accumulation can also signal for an inflammatory response. 
Shown in red is the consequence of profound PARP activation. Excessive PAR chain formation 
results in profound NAD
+
 consumption that can lead to an energy crisis, and ultimately cell death.  
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PARP Inhibition 
As a consequence of aging, PARP-1 catalytic activity is increased due to an increased 
presence of DNA strand interruptions (116, 117). PARP activity will increase drastically in response 
to DNA damage, passing basal levels by 10-500 fold (118). Thus, profound PARP activation will 
consume NAD
+
, and reduce substrate availability for other NAD
+
-utilizing enzymes. Extreme 
PARP1 activation has long been associated with necrotic cell death (114, 119). In response to DNA 
damage, this excessive up-regulation of PARP-1 activity results in a depletion of metabolic 
intermediate NAD
+
 and subsequently ATP.  With low ATP stores, an energy crisis ensues, and cells 
are no longer able to regulate cell volume leading to cell swelling, and eventually necrosis.  
These detrimental side-effects of high-level PARP activity have prompted numerous studies 
supporting the benefits of PARP inhibition. Previously shown in vascular SMCs and endothelial 
cells, inhibition of PARP1 protected against H2O2-induced cell death. This oxidative insult caused a 
drastic decrease in NAD
+
 stores, blocked by PARP inhibition (120). Further, PARP1 inhibition has 
been shown to have beneficial effects on models of chemotherapy-induced heart failure through this 
similar principle of preventing an energy crisis (121-123). Also, PARP inhibition was found to 
protect against ANGII-induced changes by maintaining NAD
+
 stores to enable continued sirt6 
function (124). PARP inhibitors have also been linked to protection from hypertrophy and ultimately 
heart failure in mice through decreased cardiomyocyte death, decreased oxidative stress, 
inflammation, and prevention of mitochondrial dysfunction (115, 125). Other reports further support 
the finding that PARP1 inhibition will reduce oxidative stress, since pro-inflammatory gene 
expression is dependent on PARP1 activation (126).   
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1.3.4 Caloric Restriction  
Endogenous oxidative stress, as a by-product of the metabolic process, links caloric-
restriction dietary regimen to prolonged lifespan. Since observing the effects of caloric restriction, 
scientists have been trying to understand the molecular basis to mimic effects without reducing food 
intake.  Within the cardiovascular system, caloric restriction confers improved risk factors of 
atherosclerosis, lowered blood pressure, increased bioavailability of NO, improved mitochondrial 
biogenesis, and lowered inflammation (127). One underlying biochemical change as a result of 
nutrient depletion is decreased cellular protein acetylation caused by decreased levels of acetyl 
coenzyme A (AcCoA), which is used as a cofactor for acetylation. This change will stimulate 
autophagy, the cellular catabolic process of breaking down and recycling dysfunctional or redundant 
cytosolic components via lysosomes (128). During times of stress, these catabolic actions will 
provide energy and building blocks for the cell and enable efficient organelle functioning, thus 
offering protective effects. Accordingly, autophagy itself through overexpression of autophagy-
related protein 5 in mice has been shown to be enough to increase longevity (129). Three molecular 
ways to mimic these changes, ultimately stimulating autophagy, have been reported: decreasing the 
pool of AcCoA; reducing activity of enzymes that use AcCoA as a cofactor; or upregulating activity 
of deacetylases (130). The Sirtuin family of proteins have been identified as mediators of the effects 
of caloric restriction, acting to alter gene expression and prolong lifespan in lower organisms through 
their deacetylase properties.  
1.3.5 The Sirtuin Family of Proteins 
The members of this Sirtuin (SIRT) family of enzymes are NAD
+
-dependent and have been 
conserved through evolution for their role in altering gene expression to facilitate regulation of 
cellular processes (131).  SIRTs will consume NAD
+
 to generate nicotinamide, which will negatively 
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feedback to inhibit SIRTs (Fig. 1.7). There are seven known mammalian SIRTs. SIRTs 1, 2, 3, 5 and 
7 act as protein deacetylases on histone and non-histone proteins to control the expression of other 
genes (132). This is consistent with the homologue in lower organisms such as Yeast, known as Sir2. 
SIRTs 4 & 6 have ADP-ribosyltransferase activity, which also requires NAD
+ 
(133). Sirtuins have 
different subcellular localization: SIRT1, SIRT6 & SIRT7 are nuclear (associating with euchromatin, 
heterochromatin and nucleoli, respectively), SIRT2 is cytoplasmic and SIRT3, SIRT4 & SIRT5 
reside in the mitochondria (134). SIRT1 is best characterized and controls various functions 
including cell differentiation, energy metabolism, circadian rhythm, stress responses and cell survival 
(135). The roles of remaining SIRTs have not been completely characterized, but have been linked to 
stress response and regulating lifespan (132). It was shown that by increasing the NAD/NADH ratio 
within cells, Sir2 activities will be up regulated to extend yeast lifespan (136).  This illustrates the 
importance of NAD
+
 homeostasis through its effects on SIRT function. 
SIRT1 
SIRT1 is abundantly expressed in the cardiovascular system (137-139). General SIRT1 
functions have demonstrated cardioprotective abilities in ischemia/reperfusion, aging and 
atherosclerosis models, but also through promoting vascular development and maintenance (140). 
More specifically, SIRT1 has beneficial effects on critical factors implicated with aging; it prevents 
endothelial senescence and dysfunction (through eNOS deacetylation) (141-144) and has anti-
oxidative and anti-inflammatory effects in cultured endothelial cells (137, 145).  More recently, 
studies using Sirt1 KO mice have linked its deacetylation function to protective autophagy through 
KO mice that exhibited increased cell death and less functional mitochondria (146). KO mouse tissue 
samples further supported loss of autophagy function through accumulation of p62 and damaged 
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organelles (147). The direct link between caloric restriction and SIRT1 was shown with these KO 
mice by losing longevity effects of a calorically restricted diet (148).   
SIRT1 over-expression models have had conflicting reports. Some literature has associated 
SIRT1 over expression with increased oxidative stress, and reduced proper mitochondria and cardiac 
functions, possibly through an NAD
+
 consumption phenomenon (149, 150). In contrast, a mouse 
study found SIRT1 over expression improved healthy aging through lower DNA damage and 
senescence, but was not sufficient to affect longevity (151). A recent study supported these findings, 
reporting that SIRT1 could promote cardiomyocyte cell survival following acute doxorubicin-
induced oxidative burden by attenuating ROS production (152). Thus there may be an optimal 
activity level and time-specific application of sirtuin function to attenuate contributing factors of 
vascular aging.   
Molecular mechanisms behind these SIRT1 findings hinge on managing ROS levels and 
targeting FOXOs, NF-κB or mTOR pathways (140). SIRT1 will deacetylate FOXOs to exploit their 
regulatory role, characterized by cellular proliferation, differentiation, genome integrity, cell survival 
and importantly oxidative stress management. Specifically, DNA damage repair response is initiated 
(153, 154), cell death is repressed through down-regulation of pro-apoptotic molecules (155) and 
antioxidant gene expression, including SOD2 and catalase, is upregulated to prevent future oxidative 
damage (156-158), thereby cohesively managing oxidative stress through SIRT1/FOXO1,3 and 4 
complexes.  Further supporting these findings, downstream of Sirt1 the formation of FOXO3a/PGC-
1α complex has been reported to regulate antioxidant genes including MnSOD, catalase, Prx3, Trx2 
and TR2 (157). The importance of these findings was emphasized in the context of the vascular 
endothelium, which is susceptible to endothelium dysfunction as a result of chronic exposure to 
oxidative stress.  Transcriptional activation of eNOS, also critical to endothelial function, has been 
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reported to be regulated by the SIRT1/FOXO pathway (159).  On another note, SIRT1 has been 
reported to supress chronic low-grade inflammation associated with aging by deacetylation of NF-κB 
and AP-1 transcription factors, thus blocking transcription of downstream pro-inflammatory 
cytokines (160-162). Finally, SIRT1 is considered a contributing promoter of autophagy through 
down-regulation of the mTOR pathway (140). 
  Critical to this project, SIRT1 maintains genome integrity by initiating downstream DNA 
repair pathways during times of stress. Post-translational and post-transcriptional modifications have 
been reported to regulate these DNA repair functions (163). Acting on SIRT1 during times of stress 
when transcription is otherwise compromised, HuR was demonstrated to translocate to the cytoplasm 
and stabilize SIRT1 mRNA, thereby increasing its presence in the cytoplasm for constitutive 
expression (164). Recently, ubiquitination post-translational modification of SIRT1 was identified as 
an essential regulator of downstream DNA damage response pathways (165). Further, SIRT1 itself 
utilizes post-translational modifications, for example through deacetylation of Nijmegen breakage 
syndrome protein, an initiator of DNA double strand break repair (166). Thus, during times of stress, 
SIRT1 is carefully regulated to promote repair pathways.  
SIRT6  
SIRT6 affects cardiac biology as a regulator of DNA damage repair, telomere maintenance 
and the metabolism of glucose and lipids (167).  These SIRT6 functions have been elucidated 
through knockout models. For example, genomic instability was identified in mice with SIRT6 
deficiency through increased sensitivity to H2O2, consistent with deficiency in BER (168). Acting 
through deacetylation of chromatin, SIRT6 may increase access of repair machinery to sites of DNA 
damage (169). Alternatively, SIRT6 may be indirectly promoting BER through activation of the 
PARP family of proteins (170, 171). Double-strand break repair may also be mediated indirectly by 
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increased PARP activity but also through non-histone deacetylation of CtIP (C-terminal binding 
protein interacting protein), a key protein involved in DSB end resection (172). Further, it was 
reported that SIRT6 may form a macromolecular complex to stabilize DNA-dependent protein kinase 
with chromatin at the site of DSBs to enable repair (173). SIRT6 deficiency may further contribute to 
genomic instability through impaired telomere capping, normally mediated by SIRT6 deacetylation 
of telomere chromatin (174).  
Contradicting literature has reported SIRT6 to alter both pro-inflammatory and anti-
inflammatory signalling pathways. The difference may depend on the cell types studied (167). SIRT6 
was found to regulate TNF-α ligand by enhancing its secretion from the cell (175) and increasing its 
translational efficiency (176). TNF-α is a common pro-inflammatory cytokine that functions to 
activate NF-κβ. Distinct research conducted in parallel found that SIRT6 physically interacted with 
an NF-κβ subunit to deacetylate promoter residues of a subset of target genes, thereby attenuating 
expression (177). This finding indirectly implicates anti-inflammatory effects of SIRT6.  
SIRT6 overexpression has also been linked to increasing longevity in male mice (178). 
Consistent with this, deficiency of SIRT6 has been associated with features of premature aging, 
likely through its role in genomic instability (168). Additionally, changes in regulation of SIRT6 
during the natural aging process may implicate SIRT6 down-regulation in age-associated phenotypes. 
Peroxynitrite, which increases during aging, can decrease SIRT6 activity (179). H2O2-induced 
oxidative stress has been reported to push endothelial cells towards a senescent phenotype through 
SIRT6 down-regulation (180). Further, a reported increased methylation state of sirt6 gene in humans 
with aging (age 20-79) suggests age-related repressed gene expression (181). 
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1.3.6 Cell Death: Modes and Stimuli 
Repair pathways and homeostatic maintenance adaptive responses are linked with signalling 
pathways that initiate cell death. For example, DNA damage is recognized by the cell and the cell 
cycle is paused to allow repair or trigger death. Similarly, metabolic checkpoints such as ATP/ADP 
and NAD/NADH ratios signal metabolic perturbations that if excessively severe can also trigger 
death (182). As discussed above, PARP can act as a metabolic checkpoint through energetic 
catastrophe following extensive DNA damage insults, signalling through depleted ATP, NAD
+
 and 
NADH stores (182).  
Cell death occurs when any of three events occur: loss of plasma membrane integrity, cell & 
nuclear disintegration or consumption by a neighbouring cell (183). Numerous stimuli can trigger 
signalling cascades that push a cell towards various distinct modes of cells death. These modalities 
can be classified by morphological changes and molecular definitions, yet no single molecular event 
can uniformly be used as “the point of no return” to determine death.  
Traditional classifications describe cell death subroutines based primarily on morphology: 
describing apoptosis as chromatin condensation, nuclear fragmentation and shrinking and necrosis as 
cell & organelle swelling and breakdown of intracellular contents in a disorganized manner (183).  
Incorporating molecular definitions offers more precise classification, as morphological descriptions 
hide heterogeneity in lethal signalling cascades (184). Currently, apoptosis is classified as caspase-
dependent extrinsic apoptosis or caspase-dependent or -independent intrinsic apoptosis, depending 
on the source of stimuli triggering death (184). Similarly, necrosis can be sub-defined through 
molecular events as necroptosis, a mode of regulated necrotic cell death (184).  
Molecular definitions also open avenues for cell death classifications based on specific lethal 
stimuli. PARP activation has been linked to a distinct caspase-independent mode of cell death, 
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known as parthanatos. Accumulation of PAR chains in the nucleus will induce their translocation 
into the mitochondria. There, the PAR chains bind to and initiate the release of apoptosis-initiating 
factor (AIF) (185). In turn, AIF will translocate to the nucleus resulting in fragmentation of DNA in 
distinctly larger segments than that occurring during apoptosis (186, 187). Based solely on 
morphological changes, this mode of death fell under the broad term necrosis. However, it can be 
defined as a specific type of regulated necrosis. In fact, several cell death subroutines can arise by 
PARP over-activation, specifically apoptosis, necrosis, parthanatos or autophagy, depending on 
extent of damage and resulting molecular events (Fig. 1.5). PARP activation will stabilize p53 to 
promote apoptosis at moderate damage levels (188) and PARP itself is cleaved during the apoptosis 
pathway by caspases to conserve ATP (189). However, PARP over-activation may inactivate caspase 
8 inhibiting apoptosis (190) or stimulate AMPK and inhibit mTOR pathways to promote autophagy 
through PARP-mediated ATP depletion (191).  
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Figure 1.5 Determination of cell death subroutines following oxidative stress. PARP over-
activation will catalyze excessive PAR chain synthesis. PAR chain accumulation can induce the 
nuclear translocation of AIF, initiating pathways leading to parthanatos. Synthesis of PAR chains 
will consume NAD
+
 and the following NAD
+
 salvage will consume ATP. Low levels of ATP can 
stimulate autophagy, or in extreme cases the energy crisis can initiate necrosis. Caspase family of 
enzymes will regulate cell death by cleaving PARP during times of damage to maintain NAD
+
 levels 
and instead push cells towards apoptosis. 
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1.3.7 The Central Role of NAD+ in Managing Oxidative Stress  
Nicotinamide adenine dinucleotide (NAD
+
) plays a central role as an energy signal, triggering a 
response to stress insults to assist in determination of cell fate. NAD
+
 is more traditionally 
recognized for its role as a cofactor of the hydride transfer enzymes of cellular redox reactions 
involved in energy metabolism (133). NAD
+
 is a versatile acceptor to compounds that contain 
hydrogen centers with strong nucleophilic or reducing properties. NAD
+
 will utilize its oxidizing 
properties to transfer electrons and become the reduced dinucleotide NADH (192). Thus, NAD
+
 is 
interconnected between NAD/NADH in various metabolic pathways, ensuring there is no net loss of 
the molecule to fuel oxidative metabolism by providing reducing equivalents through NADH. 
However, NAD
+
 is also used as a substrate for various NAD
+ 
consuming reactions (193). This 
creates a need for the cells to regenerate NAD
+
 to maintain proper function of SIRTs and PARPs, but 
also avoid an energy crisis through loss of ATP synthesis as NAD/NADH stores are depleted. 
Oxidative damage can be managed by preventative and/or post-damage response systems. 
There exists a carefully regulated threshold for cell death initiation based on damage pathways and 
metabolic signals. Regulation of these pathways centers on NAD
+
 levels, which fuel the sirtuin and 
PARP family of enzymes in both preventative and response measures. Further, the NAD/NADH 
ratio directly acts as a metabolic signal that can trigger death cascades.  However, with aging the 
supply systems for NAD
+
 can be impaired. Exogenous control of NAD
+
 levels may offer a 
therapeutic intervention to manage better oxidative stress insults.  
1.4 Therapeutic Potential of Exogenous NAD+ Precursors 
The potential for exogenous NAD
+
 precursors to regulate NAD
+
 homeostasis to promote 
repair response and avoid an energy crisis induced by active NAD
+
-consuming enzymes has 
important implications to vascular aging.  Higher PARP activity as a result of increased oxidative 
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damage in aged vascular tissue implicates constitutive NAD
+
 consumption as a phenomenon of aging 
(194). This highlights the importance of NAD
+
 regeneration. The therapeutic potential of precursor 
supplementation is however dependent on the expression of proper transporters to bring precursors 
into the cell, the ability of cells to tolerate changes in cellular NAD
+
 levels and tissue specific 
expression of required salvage enzymes. 
1.4.1 Aging as an NAD+-Deficient System 
Increased NAD
+
 consumption in aging contributes to the need for salvage pathways. 
However, impaired salvage as a result of age-associated changes suggests that aging is an NAD
+
-
deficient system.  Lower overall NAD
+
 levels have been reported in various aged rat and human 
tissues (195, 196). Declining levels can be explained by increased consumption such as chronic 
PARP activation in aged models (194), but also changes in mitochondrial function and salvage 
enzyme expression. Changes in circadian clock machinery have been reported to lower levels of key 
salvage enzyme, NAMPT, as well as NAD
+ 
(192, 197). More directly, NAMPT expression levels 
have been reported to decline in aged mice (198). Chronic inflammation was implicated as a 
causative factor of these drops through TNF-α, a major inflammatory cytokine, and oxidative stress 
both lowing NAMPT and NAD
+
 in primary hepatocytes (198, 199). Mitochondria homeostasis is 
impacted by declining NAD
+
 levels, requiring more resource input to generate ATP in less functional 
mitochondria in aged tissue (80). Taken together, increased consumption, decreased biosynthetic 
capacity and lower energy production efficiency contribute to an NAD
+
-deficient system in aged 
models.  
1.4.2 Uptake Transporter 
Cellular uptake transporters that allow nucleosides (such as NAD
+
 precursors nicotinamide 
(Nam), nicotinic acid (NA) or nicotinamide riboside (NR)) to enter cells have been characterized. NR 
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and NA are brought into the cell through high affinity major facilitator superfamily transporters Nrt1 
and Tna-1, respectively; a transporter for Nam has not yet been identified (200, 201). Pathways for 
NA and NR export have also been identified, although the mechanism and purpose for export are 
unknown (201). Speculations have suggested precursors are exported to store vitamins extracellularly 
or cross-feed surrounding cells. Nrt1 and Tna-1 transporters are not bidirectional, as export pathways 
have been found to be independent of these enzymes. Interestingly, in conditions of high NA or 
Nam, NR export will increase. Further, NR import remains low when other precursors are plentiful 
(202). In contrast to nucleoside import mechanisms, nucleotides including NAD
+
 and NMN must be 
degraded extracellularly before being brought into the cell, requiring an additional step and lowering 
bioavailability (203).  
1.4.3 Key Enzymes Involved in NAD+ Salvage Pathway 
NAD
+
 can be generated through two broad pathways in mammals: the de novo pathway from 
L-tryptophan amino acid precursor and the salvage pathway from precursors such as Nam, NA or NR 
(Fig. 1.6). Nam and NA together are also known as niacin or vitamin B3. Nam and NA are generated 
in parallel with ADP-ribosyl products following NAD
+
 catabolism. Key expression differences in 
enzymes between cell types and tissues have been identified, revealing tissue-specific pathways for 
NAD
+
 biosynthesis (204).  
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Figure 1.6 Pathways for NAD
+
 regeneration. This image illustrates the role of NAMPT 
(nicotinamide phosphoribosyltransferase), the rate-limiting enzyme in the regeneration pathway, as 
well as the role of other key enzymes, such as Nrk1 (nicotinamide riboside kinase) and NMNATs 
(nicotinamide mononucleotide adenylyltransferases), discussed in this report. On the left, the longer, 
more energy-consuming de novo pathway generates NAD
+
 from amino acid precursor L-tryptophan. 
On the right, key players in the salvage pathway are depicted.  
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Nicotinamide Phosphoribosyltransferase 
Nicotinamide Phosphoribosyltransferase (NAMPT) was initially believed to be a cytokine, 
and given the name pre-B enhancing colony factor, and later an insulin-mimetic hormone called 
Visfatin (205-207). The first claim has not been supported and remains inconclusive, while evidence 
supporting Visfatin has been retracted. It is now known as one of a few enzymes involved in the 
NAD
+
-salvage pathway. NAD
+
 is consumed as a substrate by PARPs, cADPR synthases and SIRTs. 
This thesis focuses on PARPs and SIRTs.  Following consumption of NAD
+
, NAMPT will convert 
the nicotinamide by-product to nicotinamide mononucleotide as the first and rate-limiting step to 
regenerating NAD
+ 
(205) (Fig. 1.7).  Since nicotinamide is a negative inhibitor of SIRTs, this 
enzyme consequently increases SIRT activity by lowering cellular nicotinamide levels
 
(208).  
NAMPT is therefore intricately linked within the salvage pathway to maintain cellular NAD
+
 levels.  
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Figure 1.7 A closer look at NAD
+
 salvage pathway. NAD
+
 is consumed by PARPs and SIRTs to 
Nam, which feeds back to inhibit SIRT function. NAMPT catalyzes the addition of a phosphoribosyl 
group in the first step of salvage. The resulting NMN product then gains a phosphor-adenine group 
from ATP to form NAD
+
, catalyzed by the NMNAT family of enzymes.  NR enters this two-step 
salvage pathway by receiving a phosphate group from ATP to form NMN, catalyzed by Nrk1 (shown 
in red).  
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Our lab previously isolated a cell line able to undergo differentiation between an immature, 
proliferative smooth muscle phenotype to a mature, contractile state (209). In this model, NAMPT 
was identified as a factor up-regulated in the mature SMC phenotype, illustrating dynamic 
differential expression between phenotypes (210). The role of NAMPT during SMC differentiation 
presents an additional interest in the enzyme and understanding the link between NAD
+
 homeostasis 
and vascular health. 
Within a vascular aging model, NAMPT expression decreases with age (198) and decreases 
following acquisition of a senescent phenotype in SMCs. Our lab has previously shown that 
overexpressing NAMPT in SMCs and endothelial cells in culture enhances cell life span through 
SIRT1 activity and p53 degradation (211). Further, NAMPT overexpression has been shown to 
increase cellular NAD
+
 levels to promote cell survival and resistance to oxidative stress (211-213). 
Other experiments have further supported these findings by showing that incubating cells with a 
known NAMPT inhibitor will decrease the ability of cells to withstand genotoxic stress (214).  
Nicotinamide Riboside Kinase 
Although NAMPT is a major enzyme within the salvage pathway for NAD
+
, other enzymes 
such as Nicotinaminde Riboside Kinase (Nrk) and the Nicotinamide Adenylyltransferase (NMNAT) 
protein family also play a large role. Salvage of NAD
+
 from nicotinamide riboside precursor can 
occur through two pathways. One of these involves human Nrk1 or Nrk2 phosphorylation of NR and 
the second pathway, independent of these enzymes, entails using yeast Urh1 and pnp1 enzymes to 
split NR into a ribosyl product and Nam (215).  Nam can then be used to regenerate NAD
+
 through 
alternate salvage pathways. The relevance of pathways involving these two yeast enzymes have not 
yet been considered in mammalian models. 
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 Nrk1 and Nrk2 differ in both structure and tissue-specific function. They share 57% 
homology; Nrk1 is a polypeptide of 199 amino acids, whereas Nrk2 is 230 amino acids (216). An 
additional splice form of 186 amino acids exists for human Nrk2, functionally identified as a muscle 
integrin β1 binding protein that regulates cell adhesion and laminin deposition in myoblasts (217). 
This 186 amino acid muscle integrin β1 binding protein lacks enzymatic activity, in contrast to the 
human and yeast Nrk1 with high specificity for phosphorylation of nictonamide riboside (216). The 
230 amino acid human Nrk2 enzyme has a reported 25% enzymatic activity relative to that of Nrk1 
(216).  
1.4.4 Nicotinamide Riboside Supplementation 
For decades niacin (consisting of NAD
+
 precursors Nam and NA) has been used to 
therapeutically treat dyslipidemia by lowering triglycerides circulating in the blood stream and 
raising HDL levels (218). However, two clinical trials have reported that niacin did not reduce 
cardiac events in high risk patients (219). Additional studies suggest that niacin’s benefits on 
vascular health act independently of its lipid-lowering effects (220-222). Instead, recent work 
suggests that niacin can improve endothelial function and reduce oxidative stress (223), thereby 
enabling stress management in models of ischemia & reperfusion injury or stroke (224). The 
mechanism of niacin’s actions is unclear. It is possible that benefits of niacin are mediated by distinct 
signalling pathways downstream of the niacin receptor. Alternatively, benefits through niacin 
supplementation could act in part by increasing NAD
+
 levels, although this has yet to be determined. 
NMN supplementation has been reported to overcome age-associated NAMPT decline to 
protect the heart from ischemia & reperfusion injury (225) and to treat diabetes in aged mice (198). 
Both of these studies identified compromised NAD
+
 levels by either ischemic insult or high fat diet. 
NMN was shown to protect from damage insults and protective effects were mediated by restoring 
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NAD
+
 levels. In two additional studies, NMN was found to overcome NAD
+
 decline, induced by 
age-associated increases in PARP activation (80, 194). As discussed, NMN is degraded to NR or NA 
and brought into the cell through their respective transporters. Consequently, additional signalling 
pathways may be involved in the reported protection. 
In vascular aging, NAD
+
 levels are also compromised. Vascular pathology is associated with 
chronic oxidative stress (65, 226-228) that can induce NAD
+ 
depletion (194-196). There are many 
molecular pathways that may be contributing to decreased NAD
+
 levels including PARP activation, 
declining NAMPT expression, nutritional deficiencies, etc.  Notably, all of these pathways centre on 
vulnerability of NAD
+
 supply systems in aged tissues. Currently no studies directly addressed the 
therapeutic potential of elevating NAD
+
 levels in vascular cells or models of vascular aging.  
NAD
+
 precursor supplementation offers a potential mechanism to elevate NAD
+
 levels. 
Currently, there are limitations to NA, Nam and NMN supplementation. The limitation of NMN is an 
additional step for uptake; NA results in flushing side effect (229, 230), and Nam inhibits SIRT 
activity (231). NR has the potential to overcome limitations of these precursors while still providing 
the benefits of elevated NAD
+
. Importantly, only NR has been identified as a nutrient naturally 
present in the human diet.  As a nutrient in milk, NR offers a favourable mechanism of absorption 
into the cell (216).  NR has been observed to stably elevate NAD
+
 levels, and increase NAD
+
 
bioavailability in HEK293, Neuro2a, AB1, C2C 12 and Hepa1.6 mammalian cell lines (232, 233). In 
addition, NR has potential therapeutic benefits over nicotinamide. Nicotinamide has been reported to 
negatively affecting SIRT activity, whereas NR increases SIRT activities (233, 234). Further, niacin 
(consisting of NA and Nam) has been known to induce painful flushing; these side effects may be 
avoided by instead administering NR (218). The ability of NR delivery to control NAD
+
 homeostasis 
in vascular cells has not been determined.  
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NR delivery is an emerging field. Within the last decade, it was recognized for facilitating 
downstream biosynthetic pathways to extend lifespan in yeast (202, 216). Current literature is 
expanding these findings to determine benefits in vertebras.  One of the first in vivo reports identified 
NR’s ability to stably elevate NAD+ levels in mouse tissue, enhance oxidative metabolism and 
overcome harmful effects of a high fat diet, mediated by SIRT1 signalling (233). Additionally, this 
study reported increase mitochondrial biogenesis and increased activity of SIRT3, which resides in 
the mitochondria. A more recent study reported that NR protected against noise-induced hearing loss 
in mice, in a SIRT3-dependent pathway (234). Although the mechanism behind this protection was 
not explored in depth, mitochondrial dysfunction inducing increased ROS is established as a feature 
of noise-induced hearing loss. Additionally, NR was reported to elevate NAD
+
 levels and protect 
against two distinct models of mitochondrial disease in mice (235, 236). These studies have recently 
been expanded to human cells; NR delivery and PARP inhibition were reported to restore 
mitochondrial membrane potential and oxidative activity in human fibroblasts (237). Mitochondrial 
dysfunction is a hallmark of aging and effective energy metabolism is essential to support repair 
responses during oxidative insults.  
In another study, both PARP inhibition and NR delivery were observed to overcome 
neurodegeneration-associated phenotypes induced by mutations to DNA repair proteins (238). 
Interestingly, this study looked at NRs effect on the transcriptome of diseased mice and found that 
NR normalized gene ontology terms for DNA damage repair, DNA damage response and oxidative 
stress. Additionally, NR delivery has been reported to prevent DNA damage and tumor formation in 
a model of mouse hepatocellular carcinoma (239). However, the direct effects of NR on DNA 
damage repair have yet to be explored. Vascular aging is associated with oxidative-stress-induced 
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DNA damage and PARP activation. Therefore, these studies support rationale to explore NR delivery 
in vascular cells and oxidative stress models.  
In summary, vascular aging is associated with chronic oxidative stress (65, 226-228). 
Oxidative-stress-induced DNA damage will activate PARP and NAD
+
 consumption pathways (194-
196). Thus, there is growing appreciation for the impact of NAD
+
 biology in aging to maintain 
oxidative stress responses. In aging, the supply of NAD
+
 is particularly vulnerable due to constitutive 
PARP activation, declining NAMPT expression, and relative nutritional deficiencies.  NR delivery is 
an emerging intervention to combat this NAD
+
 deficiency. Current literature has reported that NR 
will elevate NAD
+
 levels to promote mitochondrial health and protect against metabolic disease 
(233-237). Some reports have indirectly linked NR to oxidative stress response and DNA damage 
repair pathways in diseased mouse models (238, 239). However, the role of NR delivery in these 
pathways remains unclear.  Additionally, the potential benefit of NR delivery on vascular cells is 
currently unknown.  
1.5 Aims and Hypothesis 
I hypothesize that control over NAD
+
 homeostasis in vascular cells can be obtained by delivery of 
nicotinamide riboside and that this imparts resistance to oxidative stress insults with enhanced 
repair of DNA damage. 
To test this hypothesis, I will address two aims: 
1. To determine if exogenous delivery of NR increases NAD
+
 content in endothelial cells and 
smooth muscle cells, at baseline and following acute oxidative stress. 
2. To determine if NR delivery improves viability of vascular cells subjected to oxidative stress 
and imparts resistance to DNA damage and premature senescence. 
43 
 
 
 
2 – MATERIALS AND METHODS 
2.1 Reagents 
High capacity cDNA reverse transcription kit and TaqMan real-time quantitative PCR 
reagents including primer probes were from Applied Biosystems (Streetsville, ON). Qualitative PCR 
reagents, cell culture reagents, HAEC cell line, SYBR-safe, lipofectamine RNAiMAX Reagent and 
goat anti-mouse Alexa Fluor 546 were from Life Technologies (Burlington, ON). Agarose was from 
BioShop (Burlington, ON). Nicotinamide Riboside from High Performance Nutrition (Newport 
Beach, CA). Anti-PAR polymer mouse monoclonal antibody was from Trevigen (Gaitherburg, MD). 
Hydrogen peroxide was from VWR International (Mississauga, ON). Comet Assay reagents and 
EGM-2 SingleQuots were from Cedarlane (Burlington, ON). Triton-X from EMD Millipore 
(Billerica, MA). Phenazine ethosulfate, Nrk1 (E-13) antibody and Nrk1 (m) 293T lysate were from 
Santa Cruz Biotechnology (Santa Cruz, CA).  RNAeasy Mini Kit and SYBR Green PCR master mix 
were from QIAgen (Maryland, USA). Anti 8-Hydroxydeoxyguanosine monoclonal antibody was 
from Northwest Life Science Specialties (Vancouver, WA). Alexa Fluor 488 Phalloidin dye was 
from Cell Signalling Technology Inc. (Danvers, MA). Primers for qualitative PCR & SYBR Green 
PCR, lysis buffer and NAD
+
 assay reagents were from Sigma-Alderich (St. Louis, MO). 
2.2 Global Nampt knockout mice 
Inducible global Nampt knockout (KO) mice were generated on a C57Bl/6 background. 
Nampt
flox/flox
 mice were crossed with a transgenic mouse line expressing Cre recombinase fused to 
the mutated ligand binding domain of the human estrogen receptor under the control of a chimeric 
cytomegalovirus immediate-early enhancer/chicken β-actin promoter (Jackson Laboratories, ME). 
The knockout was induced by injection with 1 mg/10 g body weight of tamoxifen for 5 consecutive 
days. Animal procedures were approved by the Western University Animal Care Committee. 
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2.3 mRNA Extraction From Tissue and Cells 
Various tissues, including aorta, brain, heart, liver and skeletal muscle, were harvested from 
3-month old wildtype or Nampt KO mice perfused with PBS. Samples were placed in 1.5 mL tubes 
and immediately frozen in liquid nitrogen. A small piece of the tissue sample was then homogenized 
in Trizol using a motorized pestle and stored in the -80°C freezer overnight.  
In the case of cells, media was aspirated from confluent plates which were then washed with 
PBS. Trizol reagent was added to plates and incubated for 5 min at room temperature. The plate was 
then scrapped and contents were transferred to a 1.5mL tube.  
The following protocol was followed for both tissue and cell samples. After trizol was added 
to the homogenate, tubes were shaken vigorously and then incubated for 3 min at room temperature. 
Samples were centrifuged for 15 min at 12,200 rpm at 4°C. The aqueous phase was then transferred 
to a fresh tube. Part two of the protocol followed QIAgen RNeasy kit instructions. The RNA was 
then eluted using 30 μL of RNase-free water and a 1 min spin at 12,200 rpm.   
2.4 High Capacity cDNA Reverse Transcription 
The concentrations and integrity (260/280) of RNA samples were determined by Nano-Drop 
spectrometry (Wilmington, DE). The volume of RNA to be taken from each sample was calculated 
to obtain 1 μg of RNA for the reaction. Each sample was added to a 1X master mix without RNase 
inhibitor, including 1X RT buffer, 1X RT random primers, 10 mM dNTP mix, reverse transcriptase 
and nuclease-free water. Reverse transcription reaction was run using suggested optimized conditions 
of 10 min at 25°C, 120 min at 37°C and 5 sec at 85°C on a Eppendorf Master cycler Gradient S 
thermal cycler.  
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2.5 Qualitative PCR DNA Amplification 
Respective primers were used to amplify various genes within the NAD
+
 regeneration 
pathway including Nampt, Nmnat1-3 and Nrk1&2 and the sirtuin family Sirt1-7. A mastermix 
including 1 mM dNTP, 1.5 mM MgCl2, 1 µM reverse and forward primer stocks, 1X PCR buffer, 
Platinum Taq DNA Polymerase and sterile water was aliquoted into PCR nanotubes to which 100 ng 
of cDNA was added. The thermal cycler ran 30 cycles with a 58°C annealing temperature for 30 sec, 
72°C for 30 sec and 95°C for 30 sec. 36B4 housekeeping gene was used as an internal control. 
Wildtype kidney sample was used as a positive control in the sirtuin expression profile. 
2.5.1 Gel Electropheresis 
Gels were prepared using 1XTAE buffer (diluted from 50X TAE made with 24% Tris buffer, 
10% 0.5M EDTA at pH 8.0 and 6% acetate), 2% agarose and 3µL SYBR-safe per 50mL of buffer. A 
100 bp ladder was used to verify the size of PCR products. Following sufficient separation of 
amplified products through electrophoresis at 500 A and 100 V, gels were imaged with a UV 
transilluminator (UVP, Upland, CA).  
2.6 Quantitative Real Time-PCR Analysis (TaqMan) 
Following reverse transcription, 50 ng cDNA was added to RT quantitative PCR reaction mix 
consisting of 2X PCR master mix and 20X TaqMan Gene Expression assay. Wildtype and knockout 
tissue samples were probed for Nampt primer (Mm00451934_m1) and normalized to Gapdh 
(Mm03302249_g1). Using a 7900HT Fast Real-Time PCR system with Sequence Detection Systems 
software version 2.3, relative abundance was determined using the threshold cycle at which 
amplicons generated are sufficiently above background signal. Samples were run in triplicates.  
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2.7 Cell Culture 
Cells were cultured in 37°C conditions with 5% CO2 atmosphere. Two cell lines were 
maintained, Human Aortic Endothelial Cells (HAEC, cell passage 13-21) and HITC6 smooth muscle 
cells (HSMC, cell passage 26-32).   
(1)  HSMC, a clonal line derived from human internal thoracic aorta, were grown in M199 +10% 
FBS, streptomycin/penicillin and L-glutamine and passaged at 90% confluence using 2.5% 
Trypsin-EDTA. When ready for experiments, cells were split and grown in MEM (custom- 
without nicotinamide) supplemented with 10% FBS, streptomycin/penicillin and L-
glutamine.  
(2) HAEC were cultured in M199 +EGM-2 SingleQuots, streptomycin/penicillin and L-
glutamine and passaged at 90% confluence using 1: 10 2.5% Trypsin-EDTA. When ready for 
experiments, cells were plated in MEM (custom- without nicotinamide) supplemented with 
EGM-2 SingleQuots, streptomycin/penicillin and L-glutamine. 
2.8 Western Blot of Nrk1 
 Cells were grown on a 100 mm plate to 80% confluence in MEM (without nicotinamide). 
Protein was extracted by incubation with 4°C RIPA buffer (with protease inhibitor cocktail and 
phenylmethanesulfonylfluoride) for 5 min on ice, and scrapped with a cell scrapper. Lysate was 
agitated during 15 minute incubation on ice, before being stored in the -80°C freezer for no more 
than 3 weeks. Protein concentration was assessed using Pierce BSA Protein Assay kit and read at 660 
nm on a Thermo Electron Corporation microplate reader with Multiskan Ascent software after 20 
min incubation. A gel was prepared: top third consisting of 2% polyacrylamide for stacking and the 
bottom two thirds of 12% polyacrylamide for resolving. Polymerization with initiated with equimolar 
ammonium persulfate and TEMED. Protein was then diluted with RIPA to 45 μL to obtain 100 μg 
47 
 
 
 
protein in samples and 10 μg protein in positive control. 4X loading dye with 10% β-
mercaptoethanol was added to bring the final volume to 60 μL. Samples were loaded and gel was run 
at 80 V for 2 h. Samples were transferred to a 0.45 μm pore membrane at 110 V for 1 h.  
 Membrane was blocked with 5% skim milk in TBS buffer with 0.1% Tween 20 (TBS/t) for 1 
h at room temperature. The primary goat polyclonal Nrk1 antibody was diluted 1:150 in 5% skim 
milk TBS/t buffer and left on the membrane overnight at 4°C, while rocking. Membrane was washed 
4x 5 min with TBS/t, incubated for 1 h with 1:10,000 secondary donkey anti-goat antibody at room 
temperature, washed with 4x 5 min TBS/t and developed following a 5 min exposure onto high 
performance chemiluminescence film (Amersha hyperfilm ECL).   
2.9 Determination of Commercial NR structure by NMR 
One commercial NR capsule was dissolved in 100% D2O (5 mg/mL) and run through a 0.2 
μm HT Tuffryn membrane. Sample was given to Western Biochemistry NMR facility for a One-
Dimensional Proton NMR experiment. NR spectrum was acquired at 25 °C on a Varian INOVA 600-
MHz spectrometer equipped with a pulse field gradient triple resonance probe. 
2.10 NAD+ Quantification 
This enzymatic cycling assay was previously described by K. Umemura and H. Kimura in 2005 
(240). 
2.10.1 Experimental Set-Up 
For dose-response experiments, HAEC and HSMC were pre-treated for 24 h with 0, 50, 100 
or 300 μM NR. For NAD+ quantification, cells were pre-treated for 24 h with 100 μM NR or 1 h with 
20 μM 3,4-Dihydro-5-[4-(1-piperidinyl)butoxyl]-1(2H)-isoquinolinone (DPQ) (or respective vehicle 
controls). Cells were then subjected to 30 min of 0.25 mM H2O (HAEC) or 0.2 mM H2O (HSMC) 
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with respective pre-treatments. Media was then changed and cells were given 0, 2 or 24 h recovery 
with respective pre-treatments before NAD
+
 was quantified as described below.  
2.10.2 NAD/NADH isolation from Cells 
For cell culture samples, plates were first washed with PBS and 160 μL of 0°C lysis buffer 
(10 mM nicotinamide, 20 mM NaHCO3, 100 mM Na2CO3 and 0.05% triton X-100) was added to 
each well of a 6-well plate. A cell scraper was used to detach the cells.  Samples were frozen in a -
80°C freezer. Samples were then thawed quickly in a 37°C water bath and promptly chilled to 0°C. 
The tubes were centrifuged at 12,200 g at 4°C for 5 min and transferred to a new tube. Half of the 
sample was kept at 4°C to quantify NADt. The other half of the aliquots was incubated at 60°C for 
30 min to decompose the oxidized forms of NAD
+
, to quantify NADH. 
2.10.3 NAD/NADH Quantification  
Following extraction of NAD/NADH from cells, 25-40 μL of sample were added to a 96 well 
plate in duplicates diluted with lysis buffer to a maximum volume of 50 μL/well. NAD+ was used to 
produce a standard curve. Fresh reagent mix was prepared (100 mM Tris-CL, 5 mM EDTA-Na4, 0.5 
mM 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), 0.2 mg/mL alcohol 
dehydrogenase and 1.66 mM phenazine ethosulfate) and 100 μL was aliquoted to each well 
immediately after adding 0.5M ethanol. Following 15-20 min of incubation in the dark, total 
NAD/NADH and decomposed samples with only NADH were measured by reading the absorbance 
at 550 nm on a Thermo Electron Corporation microplate reader with Multiskan Ascent software.  
The NAD/NADH levels were then standardized to the protein level. Protein was assessed using BSA 
Protein Assay kit and read on the same microplate reader after 20 min incubation. NAD
+
 was 
calculated by subtracting NADH levels from total NAD/NADH. 
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2.11 Immunostaining 
2.11.1 8-oxoguanine  
HAEC and HSMC were grown on coverslips in 24-well plates to 50% confluence and 
subjected to 1 h 0.25 mM and 0.2 mM H2O2, respectively.  
1) HAEC were washed with cold PBS, fixed with 4% paraformaldehyde for 15 min at RT, and 
permeabilized in 0.4% Triton-X-100 in PBS for 15 min. Slides were then blocked with 5% 
BSA for 20 min before incubation with 1:1000 mouse anti 8-hydroxydeoxyguanosine (8-
OHdG) monoclonal primary antibody overnight at 4°C. Secondary goat polyclonal anti-
mouse 546 Alexa Flour antibody diluted to 1:1000 was left on slide for 20 min at RT. HAEC 
were then counterstained with 2.5 μg/mL DAPI for 10 min at RT. Slides were then mounted 
with PermaFluor.  
2) HSMC were washed with MEM without serum and fixed with 80% ethanol for 20 min at RT, 
dehydrated with 100% ethanol for 20 min and incubated in 0.5% Triton-X-100 in PBS for 20 
min. Slides were then blocked with 5% goat serum for 20 min before incubation with 1:200 
mouse anti 8-hydroxydeoxyguanosine (8-OHdG) monoclonal primary antibody overnight at 
4°C. Secondary goat polyclonal anti-mouse 546 Alexa Flour antibody diluted to 1:200 was 
left on slide for 20 min at room temperature. Slides were then mounted with PermaFluor.  
2.11.2 PAR chains 
HAEC and HSMC were grown on coverslips in 24-well plates to 70% confluence and 
subjected to 10 min 0.25 mM and 0.2 mM H2O2, respectively. Cells were washed with cold PBS, 
fixed with 4% paraformaldehyde for 15 min at 4°C and permeabilized with 0.4% triton-X in PBS for 
15 min at RT. Cells were blocked with 5% BSA and incubated with 1:500 anti-PAR polymer 
primary mouse monoclonal antibody in 5% BSA overnight at 4°C. Secondary goat anti-mouse Alexa 
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Fluor 546 antibody diluted to 1:1000 was left on cells for 30 min at room temperature. Cells were 
counterstained with 2.5 μg/mL DAPI for 10 min. Coverslips were then mounted with PermaFluor 
onto microscope slides.  
Immunostained cells were imaged using with Northern Eclipse software on an Olympus 
BX51 microscope. 
2.12 Cell Shrinkage and Viability 
HAEC and HSMC cells were grown to 80% confluence and pre-treated for 24 h with 100 μM 
NR or 1 h with 20 μM DPQ (or respective vehicle controls). Cells were then subjected to 4 h 
treatment with 0.25 mM (HAEC) or 0.2 mM (HSMC) H2O2 with respective pre-treatments and 
imaged using time-lapse Leica Application Suite Advanced Fluorescence software on a Leica DMI 
6000B microscope.  Immediately following image acquisition, cells were incubated for 5 min with 
100% Trypan Blue (0.4%), and dead/alive cells were recorded (N=1 represents a full experiment), 
which was determined by presence of dye within the cytoplasm. Time-lapse videos were quantified 
using ImageJ to trace the area of cells at time 0, 2 and 4 h (n=1 represents one cell).  
2.13 Actin Cytoskeleton Staining 
 HAEC and HSMC were grown on coverslips in 24-well plates to 50% confluence, pre-treated 
with 100 μM NR for 24 h (or vehicle control) and then subjected to 1 h 0.25 mM and 0.2 mM H2O2, 
respectively. Cells were rinsed with PBS at room temperature, fixed with 4% paraformaldehyde for 
20 min at 37°C, permeabilized for 5 min with 0.5% Triton-X-100 and stained for 20 min with 1:50 
phallodin 488. Slides were then counterstained with 2.5 μg/mL DAPI and mounted with PermaFluor. 
Slides were imaged using with Northern Eclipse software on an Olympus BX51 microscope. 
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2.14 Alkaline Comet Assay 
2.14.1 Experimental Set-Up 
For tail moment analysis following H2O2, cells were pre-treated for 24 h with 100 μM NR or 
1 h with 20 μM DPQ. Cells were then subjected to 30 min or 1 h treatment with 0.25 mM (HAEC) or 
0.2 mM (HSMC) H2O2 with respective pre-treatments. Media was then changed and cells were given 
0-11 h recovery with respective pre-treatments. Experiment time-line is depicted below. Stars 
represent time-points when CometAssay was run.  
 
 
2.14.2 Single Cell Gel Electrophoresis Assay 
 CometAssay kit was run according to Trevigen’s supplied instructions for alkaline comet 
assay. Briefly, cells were incubated in trypsin for 1 min, neutralized with MEM and spun in a 1.5 mL 
microtube tube for 5 min at 800 rpm at 4°C in an Eppendorf Centrifuge 5415D. Cells were then re-
suspended to 1x10
5
 cells/ mL in cold PBS. Then, 10 μL of cell suspension was plated in 100 μL 
molten Comet LMAgrose and allowed to chill for 20 min in 4°C fridge. Once chilled, supplied lysis 
solution was put on gels and incubated overnight in 4°C fridge. Alkaline Unwinding Solution (200 
mM NaOH, 1 mM EDTA, pH>13) was left on cells for 20 min at room temperature. Plates were then 
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transferred to a gel electrophoresis apparatus filled with Alkaline Electrophoresis Solution (300 mM 
NaOH, 1 mM EDTA, pH>13) on a bed of ice. Samples were run at approximately 300 mA and 17.5 
V for 25 min. Plates were then stained for 30 min with 1:10000 SYBR Gold (DMSO vehicle) diluted 
in TE buffer (10 mM Tris-HCL pH 7.5, 1 mM EDTA). Plates were dried completely and mounted 
with ProLong Gold Antifade Reagent.   
2.14.3 CometAssay Analysis 
 OpenComet version 1.3 was used for automated analysis of comet assay images (241). This 
validated open-source software program is a plugin for ImageJ.  
2.15 Quantitative Real Time-PCR Analysis (SYBR Green) 
The sequences of forward and reverse primers for SIRT1-7 and anti-oxidant genes are listed 
in appendix A. Expression levels were normalized to the single-copy gene, acidic ribosomal 
phosphoprotein PO (36B4).The sequence of the 36B4-specific forward (36B4) and reverse (36B4) 
primers was 5’ ACT GGT CTA GGA CCC GAG AAG 3’ and 5′TCA ATG GTG CCT CTG GAG 
ATT 3’, respectively.   
Each reaction sample contained 5 µL of RT
2
 SYBR green master mix with ROX 
(SAbiosciences, 300 nM of respective primers, 180-500 ng cDNA and nuclease-free water to yield a 
total volume of 10 µL.  Samples were assayed in triplicates on a 384-well plate.  The following 
thermal profile was used 95°C hot start for 10 min, followed by 40 cycles of denaturation at 95°C for 
15 sec, and anneal-extension at 60°C for 1 min.  The experiment was carried out using a ViiA7 PCR 
machine (Life Technologies, Burlington, ON).  The data were exported to Microsoft Excel and the 
ΔΔCt was calculated for each sample to compare expression levels changes to control.    
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2.16 siRNA Transfection to knockdown SIRT1-7 
 HAEC and HSMC were grown in a 24-well plate (cell-shrinkage, viability and senescence 
experiments) or 12- well plate (tail moment analysis) to 70% confluence. For 24-well plate, 5 pmol 
respective siRNA and 1.5 μL Lipofectamine RNAiMAX in 50 μL Opti-MEM Medium was added to 
each well. These values were doubled per well for 12-well plates. Cells were incubated with 
transfection reagents for 48 h with 100 μM NR. Media was changed to fresh media with 100 μM NR 
for 24 h before use in cell shrinkage, viability and tail moment experiments.  
2.17 Senescence Associated β-Gal 
 HAEC and HSMC were grown on coverslips in 24-well plates to 50% confluence, pre-treated 
with 100 μM NR for 24 h or 1 h 20 μM DPQ (or respective vehicle controls) or siRNA transfection 
protocol section 2.15. Cells were then subjected to 1 h 0.025 mM (HAEC) and 0.02 mM (HSMC) 
H2O2 and given 48 h recovery in fresh media. Cells were then rinsed with PBS, fixed for 3 min 
(fixative: 2% formaldehyde & 0.2% gluteraldehyde in PBS) and stained for 6 h at 37°C without CO2 
(staining solution: 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mM NaCl, 2 
mM MgCl, 40 mM sodium citrate, 1 mg/mL X-Gal (dissolved in DMSO),  pH 6.0 with NaH2PO4). 
Coverslips were then mounted with PermaFluor. 
 Cells were imaged using Northern Eclipse software on Olympus BX51 microscope. Positive 
cells were determined using threshold function on ImageJ and compared to total cells in each field of 
view (n=1 represents one field of view).  
2.18 Statistical Analyses  
Statistical differences (P < 0.05) were determined by using Graphpad Prism software version 
6.0. One-Way ANOVA was used to assess the effects of one independent variable on a dependent 
variable. This test was followed by Dunnett’s Multiple Comparison Test when all groups were 
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compared to one control group or Tukey’s Multiple Comparison Test when every group was 
compared to every other group. Two-Way ANOVA was used for grouped analysis when the effects 
of two independent variables were assessed. This test was then followed by either Tukey’s Multiple 
Comparison Test when every paired group was compared to every other paired group or Sidak’s 
Multiple Comparison Test when sets of paired groups were compared.  The statistical test used is 
outlined in figure legends, corresponding to their respective experiments.  
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3 - RESULTS 
3.1 NAD+ Deficient Environment Upregulates Nrk1 mRNA Abundance 
Previous studies have reported increased uptake and metabolism of NR under NAD
+
 deficient 
conditions caused by low availability of alternative NAD
+
 precursors (202, 242). This finding sets 
the stage for testing the effect of NR delivery in aging models, where NAD
+
 levels are reported to 
decline (195, 196). Our lab has created an NAD
+
 deficient environment in mice through a tamoxifen-
induced Cre/lox Nampt knockout mouse model. Nampt is the rate-limiting enzyme in the NAD
+
 
salvage pathway (Fig. 1.6), and its knockout leads to a decline of tissue NAD
+
 content.  
To determine the effect of NAMPT knockout on mRNA abundance of NAD
+
 salvage 
enzymes, I harvested tissue from Nampt-deficient mice and their wild-type littermates and isolated 
the mRNA. To confirm that Nampt was in fact depleted, I used real-time PCR.  This revealed that 
Nampt levels decreased in aorta, brain, heart and skeletal muscle following injection with 1mg/10g 
body weight of tamoxifen for 5 consecutive days. The observed changes varied in a tissue-specific 
manner (Fig. 3.1A). This variability might be attributed to differential tamoxifen accessibility, Cre 
expression or cell turnover in tissue (243). Next, I compared the abundance of NAD
+
 salvage enzyme 
mRNA transcripts in Nampt KO to wild-type littermates using reverse transcription-quantitative PCR 
(RT PCR). This revealed differential regulation of NAD
+
 salvage enzyme expression in low NAD
+
 
conditions (Fig. 3.1B).  Specifically, I observed a striking up-regulation of Nrk1 expression in aorta, 
brain and heart, with little to no change in expression of NMNAT 1-3 and Nrk2.  
For this vascular focused project, I specifically noted changes in the aorta tissue, comprising 
endothelial and smooth muscle cells. Following injection with tamoxifen, I used real-time PCR to 
asses Nampt KO and I observed a drop to 70% of baseline aortic Nampt mRNA levels (Fig. 3.1A). A 
distinct up-regulation in Nrk1 and possibly a decrease in NMNAT 2 expression are also seen, using 
quantitative RT PCR (Fig. 3.1B).  
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In light of previously reported tissue-specific preferential NAD
+
 salvage pathways (204), I 
compared the wild-type expression profile of NAD
+
 enzymes between aorta and other tissues. RT 
PCR was used and I found that aorta tissue expressed a full spectrum of NAD
+
 salvage enzymes, 
however tissue-dependent differences were also revealed (Fig. 3.1B). There was lower expression of 
Nrk1, under normal NAD
+
 conditions, as compared with heart, skeletal muscle, liver and kidney. The 
expression of Nrk2 in aorta was lower than in heart and skeletal muscle, which is consistent with its 
identification as a muscle integrin β1 binding protein that regulates cell adhesion and laminin 
deposition in myoblasts (217). Also interesting to note was the strong expression of NMNAT 2 in 
wild-type brain tissue, consistent with previous reports (244). 
The sirtuin family of enzymes are histone deacetylases that consume NAD
+
 to regulate cell 
survival and stress response pathways (245). To determine if their expression was effected by low 
NAD
+
 conditions, I used the same tamoxifen-induced Cre/lox Nampt knockout mouse model used in 
Fig. 3.1 A&B. Following tamoxifen injection, tissues were isolated and RT PCR was used to assess 
the levels of Sirt 1-7 mRNA in tissues from Nampt KO mice and their wild-type littermates. I found 
that the mRNA levels of all seven sirtuins remained unchanged (Fig. 3.1C). Also interesting to note 
is the ubiquitous expression of Sirt 1-7 across all of the mouse tissues examined. Specifically, aorta 
tissue showed robust Sirt1, Sirt2 & Sirt6 expression and lower levels of Sirt4, Sirt5 & Sirt7 mRNA. 
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Figure 3.1 Expression profile of enzymes within the NAD
+
 regeneration pathway and sirtuin 
family of enzymes in Nampt knockout mouse tissues and wild-type littermates.  RNA transcripts 
from mouse aorta, brain (frontal cortex), heart, liver, skeletal muscle (hind limb) and kidney tissue 
were harvested, isolated and reverse transcribed to cDNA. (A) The cDNA was amplified by 
quantitative real-time PCR. Nampt mRNA is presented as a ΔΔct comparison of knockout mouse 
sample transcript expression to wild-type littermates (n=3). (B) The cDNA was amplified by RT 
PCR using primers specific for Nmnat 1-3, Nrk1, Nrk2, Nampt, and 36B4, the latter a housekeeping 
gene used as an internal control for comparison. Products were resolved on a 2% agorose gel by gel 
electrophoresis.  (C) Primers specific for Sirts 1-7 were used to amplify cDNA by RT PCR.  The 
positive control is mouse wildtype kidney tissue, found to be ubiquitously expressed in all Sirts in 
preliminary data. The negative control is a non-template control.  [WT- wildtype, KO- Knockout, 
Skel. M.- skeletal muscle, NTC- non-template control, +ve- Positive, -ve- Negative] 
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3.2 NR Delivery Increases NAD+ Content in a Dose-Dependent Manner 
Direct entry of NR into the NAD
+
 salvage pathway depends on both a functional uptake 
transporter to bring NR into the cell and on Nrk1 to catalyze the phosphorylation of NR to NMN 
(202). I examined NR delivery into vascular cells, using human aortic endothelial cells (HAEC) and 
human smooth muscle cells (HSMC). Acting on the evidence delineated above for preferential NR 
salvage in NAD
+
-depleted conditions, vascular cells were plated in NAD
+
 precursor free MEM 
media with cell-specific supplements for experiments. However, to maintain normal growth prior to 
experiments, cells were cultured in regular growth media for passages.   
To determine if Nrk1 is expressed in vascular cells, I assessed mRNA and protein abundance. 
To do this I used quantitative real-time PCR analysis using primer probe for human Nrk1 and I 
confirmed that HSMC and HAEC express Nrk1 mRNA (ct=26.262, 24.823, respectively). To assess 
Nrk1 protein abundance, I used a Western Blot, which revealed a 23 kDa protein comparable to a 
positive control of mouse NRK1 transfected whole cell lysate (Fig. 3.2A). The difference in 
molecular weight of the expressed protein compared to positive control may be accounted for by 
human versus mouse splice variants. Using protein BLAST, NRK1 Mus musculus sequence was run 
and found to have significant alignment with NRK1 isoform 1 Homo sapiens (81% identity) and 
NRK1 isoform 2 Homo sapiens (69% identity). The differences in position and alignment of amino 
acid residues may account for the observed difference in molecular weight. 
Exogenous supplementation of NR has been reported to increase cellular NAD
+
 levels in a 
dose-dependent manner in yeast, mouse myoblast, mouse heptoma and human embryonic kidney cell 
lines (202, 233). An increase in intracellular NAD
+
 levels in response to NR supplementation would 
confirm that NR could be brought into vascular cell and metabolized to NMN, thereby entering the 
NAD
+
 salvage pathway. To assess these foundations for NR delivery in vascular cells, I incubated 
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HAEC and HSMC with 50-300 μM NR for 24 h. NAD+ levels were quantified through an enzymatic 
cycling assay, developed from a published protocol (240). Intracellular NAD
+
 levels in HAEC 
significantly increased by 26±3%, 35±4% and 41%±2 (p<0.0001) in response to 50, 100 and 300 μM 
NR, respectively (Fig. 2B). In HSMC, an increase of 34±9% (p=0.33), 62±9% (p=0.02) and 80±30% 
(p=0.002) in NAD
+
 levels was observed in response to 50, 100 and 300 μM NR, respectively. These 
findings suggest a functional Nrk1 was present and established that NR supplementation increased 
NAD
+
 content in vascular endothelial and smooth muscle cells.   
3.3 Source for NR Supplementation 
When this project began three years ago, there were limited options for acquiring NR. 
Preliminary dose-response experiments used NR purchased from Toronto Research Chemicals, 
which was very costly. As the project expanded, a more cost-effective and abundant supply of NR 
was needed. I partnered with the Shilton Lab to synthesize NR using a previously published protocol 
(246). The purity of this synthesized NR was confirmed using one dimentional-
1
H spectrum analysis 
(data not shown). This source of NR was less costly; however it was labour intensive and time-
consuming for the Shilton Lab.  Both of these sources of NR were used to generate reproducible 
dose-response curves, reported in Fig. 3.2. The synthesized NR was then used for preliminary cell 
shrinkage, viability and NAD
+
 quantification experiments, discussed later.  
Within the last year, commercially available NR supplements have emerged on the market, 
offering a cost-effective and abundant source of NR.  I decided to switch sources of NR from 
synthesized NR to the commercial NR capsules to: i) reproduce results using an additional source of 
NR; ii) use a source of NR readily available to the public; and iii) build foundations for future in vivo 
work. To determine the purity of commercially available NR, as well as its stability following 
preparation for experimental use, a sample of NR was given to Western Biochemistry NMR facilities 
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for one dimentional-
1
H spectrum analysis. NR extracted from a commercially available capsule 
(NIAGEN® ChromaDex, purchased from High Performance Nutrition) was dissolved in 100% D2O 
to avoid the interfering signal caused by H2O. According to the spectrum analysis, the purity of NR 
was found to be 92%, using previous literature for proton assignment (Fig. 3.2D) (232). The 
calculated integrals of the less intense peaks in the 8.0-9.6 ppm region represent impurity of 
8.4±1.4%, possibly arising from nicotinamide. The less intense peaks in the lower ranges may have 
been caused by debris from the filter, used to prepare NR capsules for experimental use. Speculations 
on the source of impurity cannot be confirmed by this proton spectrum.  
The commercial source of NR was then used to reproduce preliminary data generated by the 
synthesized NR (Fig. 3.4 and 3.5). Once its protective effects on cell shrinkage and viability were 
confirmed, the commercial source of NR solely was used for the remaining experiments.  
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Figure 3.2 Model for NR delivery in vascular cells. (A) Western blot of HSMC and HAEC (40 μg 
protein) probed with goat polyclonal Nrk1 antibody and compared to positive control from mouse 
Nrk1 transfected whole cell lysates (10 μg protein). (B-C) Graphs show effects of NR 
supplementation on NAD
+
. Cells were cultured in NAD
+
-precursor-free MEM media. NAD
+
 was 
extracted from cells and levels were quantified using an enzymatic cycling assay, 24 h following 0-
300 μM NR supplement to HAEC, mean ± SEM (n=6) (B) and HSMC, mean ± SEM (n=9) (C). 
*Significant compared to control (p<0.05) using One-way ANOVA and Tukey’s Multiple 
Comparison Test of the means. (D) One-dimensional proton spectrum of commercially available NR 
(5 mg/mL) in 100% D2O. The H’s are assigned to the spectrum according to the structure of NR, 
displayed in the top-right corner of (D). The bonding pattern of each hydrogen to its surrounding 
atoms determined its resonance in the magnetic field, reported in ppm.  
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3.4 Acute Oxidative Stress Induces PARP-Dependent NAD+ Depletion  
To induce oxidative stress in vascular cells, I selected hydrogen peroxide (H2O2). This was 
chosen because it is a physiologically relevant stress, it is increased in aged tissues, and this results in 
oxidative lesions, NAD
+
 consumption and senescence (65). An acute dose was used in sections 3.4-
3.10 for proof of concept to assess NRs protective capacity against oxidative stress insults. I used 
preliminary cell shrinkage dose-response curves to select a dose of H2O2 at which the most 
prominent protection was observed by NR (data not shown). From this preliminary data, HSMC were 
found to be more sensitive to oxidative stress, requiring a slightly lower H2O2 dose to produce a 
response similar to HAEC. The selected dose of 0.25 mM for HAEC and 0.2 mM for HSMC was in 
the same range as previous in vitro vascular studies (120). 
Previous reports have associated oxidative stress with a decline in NAD
+
 levels, attributed to 
the activation of PARPs, a major NAD
+
-consuming enzyme, in response to oxidative DNA lesions 
(194-196).  To determine if an acute oxidative stress insult lead to the formation of oxidative DNA 
lesions in vascular cells, I used a 1 h H2O2 insult. This induced persistent oxidative lesions, assessed 
by 8-oxo-guanine positive staining in both cell types (Fig. 3.3A,B).  
PARP has been reported to recognize DNA lesions and catalyze the formation of PAR chains 
at the site of damage (111). Next, to assess PARP response to the formation of these oxidative 
lesions, I used the same acute H2O2 insult and immunofluorescence against α-PAR.  At 10 min, 
almost immediately after H2O2 insult began, nuclear PAR-chain accumulation was visible in both 
vascular cell types through immunofluorescence for α-PAR, which was confined to the nucleus (Fig. 
3.3C). To confirm that this response was PARP1 dependent, PARP1 specific inhibitor, 3,4-Dihrdro-
5-[4-(1-piperidinyl)butoxyl]-1(2H)-isoquinolinone (DPQ) was used.  Ten minutes after H2O2 insult, 
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nuclear α-PAR staining was abolished by the presence of DPQ (Fig. 3.3C). Thus, H2O2 induced 
oxidative DNA lesions and PAR-chain formation, in a PARP-dependent manner.  
I then examined the NAD
+
 levels in this oxidative insult model. By 30 min of H2O2 insult, 
H2O2 had induced an 86±8% drop in intracellular NAD
+
 levels in HAEC (Fig. 3.3D) and a 55±5% 
drop in HSMC (Fig. 3.3E). PARP1 has been reported to account for 90% of PARP-dependent NAD
+
 
consumption (111). To determine if the NAD
+
 decline was due to PARP1 activation, cells were pre-
treated for 1 h with DPQ and incubated with DPQ for the duration of the experiment. By 30 min, this 
revealed that PARP1 inhibitor (DPQ) significantly blocked the drop in NAD
+
 levels, observed by 
68±3% of baseline NAD
+
 levels in HAEC (P=0.0002) and 74±7% in HSMC (p=0.03). By 2 and 24 h 
following H2O2 insult, NAD
+
 levels in vehicle control group were restored to baseline levels in both 
cell types in a time-dependent manner. Similarly, DPQ-treated groups also restored NAD
+
 levels to 
baseline. This established H2O2-induced oxidative lesions resulting in PARP activation and PAR-
chain formation, in parallel with NAD
+
 consumption in vascular cells.  
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Figure 3.3 H2O2-induced oxidized DNA lesions, PAR-chain accumulation and NAD
+
 depletion 
in vascular cells.   (A) HAEC and (B) HSMC were exposed to 1 h 0.25 mM and 0.2 mM H2O2 
insult. Cells were then fixed with 80% EtOH, dehydrated with 100% EtOH and permeabilized with 
0.4% Trtion-X in PBS and stained with 1:200 8-oxo guanine primary antibody (red). HAEC, but not 
HSMC, were counter-stained with 2.5 μg/mL DAPI (blue). Exposure to H2O2 induced oxidative 
lesions within the nuclei, visualized by red fluorescence. (C) HAEC and HSMC were exposed for 10 
min with 0.25 mM and 0.2 mM H2O2, respectively, following pre-treatment for 1 h with 0.8% DMSO 
or 20 μM DPQ. Cells were then fixed using 4% paraformaldehyde, permeabilized with PBS + 0.4% 
triton X, immunostained with 1:1000 α-PAR primary antibody (red) and counter-stained with 2.5 
μg/mL DAPI (blue). Exposure to H2O2 induced PAR-chain accumulation within the nuclei, 
visualized by red fluorescence. Pre-treatment with DPQ reduced accumulation of PAR-chains and 
image resembles that of control cells without H2O2 treatment.  Bar on bottom right of images 
represents a 50 micron scale. (D-E) Cells were grown in NAD
+
-precursor-free MEM media. NAD
+
 
was extracted from cells and levels were quantified using an enzymatic cycling assay.  (D) HAEC, 
mean ± SE (n=3) and (E) HSMC mean ± SE (n=6) were pre-treated for 1 h with 0.8% DMSO or 0.2 
μM DPQ and then exposed to 30 min of 0.25  or 0.2 mM H2O2, respectively. At 0, 2 or 24 h after 
H2O2 insult, cells were harvested and NAD
+
 content was analyzed. *Significantly different than 
corresponding vehicle control group (p<0.05, using Two-Way ANOVA and Sidak’s Multiple 
Comparison Test of the means). ** Blue bars only, significant differences between indicated groups 
(p<0.05, using Two-Way ANOVA and Sidak’s Multiple Comparison Test of the means). There were 
no significant differences between 0 h and 2 h time points for both red and blue bars.  
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3.5 NR buffers NAD+ content, preserves morphology integrity and increases cell survival after 
oxidative stress insult  
To determine if NR could provide vascular cells with a reserve of NAD
+
 to sustain the NAD
+
 
consumption associated with acute oxidative insults, I pre-treated cells for 24 h with NR and 
quantified NAD
+
 levels. Consistent with Fig. 3.2B&C, pre-treatment with NR supplements provided 
a reserve of intracellular NAD
+
 by significantly increasing baseline levels by 38±8% in HAEC 
(p=0.0006) and 40±7% in HSMC (p=0.0014) (Fig. 3.4A). Next, I confirmed that the response to 
H2O2 was similar to previous experiments. I exposed cells to 30 min H2O2 and quantified NAD
+
 
levels at 0, 2 and 24 h after the insult. Consistent with Fig. 3.3A&B, NAD
+
 levels again declined in 
response to H2O2 by 87±4% in HAEC (Fig. 3.4A) and 68±6% in HSMC (Fig. 3.4B).  
Next I assessed NRs effect on NAD
+
 consumption and regeneration following an oxidative 
stress insult. NR-treated groups dropped a similar absolute value compared to vehicle controls of 
73% in HAEC and 55% in HSMC. The NAD
+
 reserve from NR supplements provided a buffer 
following H2O2 insult, with NAD
+
 levels immediately following the insult being higher than vehicle 
control by 3-fold in HAEC (p=0.051) and 2-fold in HSMC (p=0.02). During the following 2 h and 24 
h repair, NAD
+
 levels returned to their baseline levels in both cell types in a time-dependent manner. 
Importantly, the increase in NAD
+
 content above baseline conferred by NR in a given treatment 
group remained higher than untreated groups throughout the time-course experiment. 
To further assess NR’s protective capacity, cells were subjected to H2O2 for 4 h, and their 
morphology and viability was tracked. In preliminary experiments, I found that this more prolonged 
exposure to H2O2 was required to compromise morphology and viability. The longer exposure likely 
sufficiently depleted NAD
+
 stores, which resulted in notable NR protection in this model. Time-lapse 
video microscopy was used to track individual cells and changes in area were quantified at 0, 2 and 4 
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h. Following exposure to H2O2, both HAEC and HSMC appeared to shrink and cytoplasmic blebs 
were visible in vehicle-exposed cells (Fig. 3.5 A,B&G,H). However, following NR supplementation, 
many cells maintained their shape and size. A small subset of cells still strikingly shrunk (Fig. 3.5 
C,D&I,J). Quantification of cell area using image J revealed a two-fold reduction in cell-shrinkage at 
4 h of H2O2 exposure, as compared to baseline in HAEC and HSMC (p<0.0001) (Fig. 3.5 F&L).  
To determine NRs ability to protect cell viability, vascular cells pre-treated with NR were 
exposed to 4 h acute H2O2 insult and viability was quantified through trypan blue exclusion assay.  
This assay was chosen because it could be used immediately following the time-lapse experiment to 
assess cell death on the same population of cells used for morphology and cell shrinkage analysis. 
This revealed significantly greater viability in the presence of NR- 60±10% versus 35±8% in vehicle 
control in HAEC (p=0.039) and 84±6% compared to 63±9% in vehicle control in HSMC (p=0.049) 
(Fig. 3.5E&K).  
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Figure 3.4 NR buffers H2O2-induced consumption of intracellular NAD
+
 levels. Cells were 
grown in NAD
+
-precursor-free MEM media. NAD
+
 was extracted from cells and levels were 
quantified using an enzymatic cycling assay.  (A) HAEC mean ± SE, (n=12) and (B) HSMC mean ± 
SE, (n=15) were pre-treated for 24 h with 100 μM NR supplement or vehicle and then given 0, 2 or 
24 h recovery following treatment with 30 min 0.25  or 0.2 mM H2O2, respectively. * Significantly 
different than corresponding vehicle control group (p<0.05, using Two-Way ANOVA and Sidak’s 
Multiple Comparison Test of the means).  ** Blue bars only, significant differences between 
indicated groups (p<0.05, using Two-Way ANOVA and Sidak’s Multiple Comparison Test of the 
means). 
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Figure 3.5 H2O2-induced cell shrinkage and cell death is attenuated by NR delivery in vascular 
cells. HAEC and HSMC, pre-treated for 24 h with NR, were exposed to 0.25 and 0.2 mM H2O2, 
respectively, and imaged live using time-lapse Hoffman modulated contrast microscopy for 4 h. (A-
D) HAEC and (G-J) HSMC images corresponding to baseline (0 h) and 4 h after respective H2O2 
dose was added (4 h), with NR pre-treatment or vehicle. Fold change in area (±SE), measured by 
tracking cells and tracing border in Image J was recorded for (E) HAEC (n=192-224) and (K) 
HSMC (n=128).  * Shows significantly higher cell shrinkage than untreated control and significantly 
less cell shrinkage than cells not pre-treated with NR (p<0.05, using Two-Way ANOVA and Tukey’s 
Multiple Comparison Test of the means). Trypan Blue exclusion (viability ±SE) was quantified in 
cells 4 h post-insult for (F) HAEC (N=10) and (L) HSMC (N=8). * Shows significantly lower 
viability than untreated control and significantly greater viability than cells not pre-treated with NR 
(p<0.05, using One-Way ANOVA and Tukey’s Multiple Comparison Test of the means).  
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3.6 NR Preserves Morphology by Maintaining Cytoskeletal Integrity 
Morphological shrinkage, in response to oxidative damage, suggests possible cytoskeletal 
collapse. Actin is a vital component of the cytoskeleton that acts as a linker protein to focal 
adhesions, thereby maintaining cell shape (247-249). Therefore, NR’s effects on actin cytoskeletal 
structures against oxidative damage were examined using immunostaining with fluorescent 
phalloidan, a bicyclic heptapeptide specifically binding to F-actin, following H2O2.  By observing 
cells at 1 h, a snap-shot of cytoskeletal changes was possible, avoiding the full-collapse at 4 h, likely 
associated with cell death. Consistent with Fig. 3.4, a prominent change in shape and size was 
observed following 1 h H2O2 exposure in both cell types (Fig. 3.6). Stress fibres, running length wise 
through the cytoplasm, degraded into short segments, aggregated into puncta or completely collapsed 
in some cells treated with vehicle control. NR treatment enabled cells to maintain stress fibre 
integrity and resist the shrinking effect.  
Surprisingly, NR treatment led to notable actin reorganization at baseline. This was 
particularly evident in the HAEC, which revealed a shift in actin structures from cortical bundle and 
filopodia to stress fibres upon NR treatment (Fig. 3.6). NR-treated HAEC at baseline exhibited dense 
stress fibre networks, possibly acting to maintain cell morphology under episode of oxidative insult. 
Similar effects of NR to stress fibre networks were also noted in HSMC, but to a milder extent.  
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Figure 3.6 NR delivery results in actin re-organization and protects from H2O2-induced 
cytoskeletal collapse in vascular cells. Cells were pre-treated with 100 μM NR for 24 h. 
Immediately following 60 min 0.25 mM or 0.2 mM H2O2, (A) HAEC and (B) HSMC, respectively, 
were fixed using 4% paraformaldehyde, permeabilized with PBS + 0.4% triton X, stained with 1:50 
Alexa Fluor 488 phalloidin (green) and counter-stained with 2.5 μg/mL DAPI (blue). Bar on bottom 
right of images represents a 50 micron scale.  
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3.7 NR delivery promotes DNA repair efficiency. 
The previous data indicates that NR delivery augments NAD
+
 reserves in vascular cells and 
that these reserves enable the cells to better maintain morphology and viability in response to H2O2 
stress. The PARP family of enzymes rely heavily on NAD
+
 stores to fuel their highly NAD
+
-
consuming role in recruiting DNA repair machinery to sites of damage (111). Additionally, the 
sirtuin family of enzymes consume NAD
+
 for their cellular function, including maintaining genome 
integrity, stress response, and up-regulating anti-oxidant pathways to name a few (140, 245). 
Therefore, I next considered if NR played a role in promoting DNA repair responses.   
To explore the potential effects of NR on DNA repair, a delicately-controlled insult sufficient 
to induce damage, so as to deplete NAD
+
, but not kill the cell was needed. The 4 h oxidative insult in 
the previous experiment (section 3.5) induced approximately 50% death in untreated groups. The 
remaining live cells, from which DNA damage and repair would be studied, do not represent the 
entire population. The new model chosen to investigate DNA repair used the same dose of H2O2, but 
only a 1 h insult. Cells were then washed with fresh media and given variable recovery times to 
allow DNA repair. An alkaline comet assay was used to quantify both single- and double- strand 
DNA breaks. In this assay, broken DNA fragments are pulled out of the confines of the nucleus by an 
electrical current and damage is quantified by tail length, shape and intensity, compared to the size 
and intensity of the nucleus.  
One such measure is tail moment: 
𝑇𝑎𝑖𝑙 𝑀𝑜𝑚𝑒𝑛𝑡 =
(𝑇𝑎𝑖𝑙 𝐿𝑒𝑛𝑔𝑡ℎ × 𝑇𝑎𝑖𝑙 %𝐷𝑁𝐴)
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In cells not exposed to H2O2, DNA remained within the confines of the nuclei. Upon 
oxidative damage induced by H2O2, a tail representing damaged DNA species arose, was evident 
within 1 h of H2O2 exposure and then gradually diminished, indicating DNA repair (Fig. 3.7 C,D).  
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In HAEC, tail moment was significantly lowered with NR treatment at all times quantified 
(0-11 h post H2O2 withdrawal) (P<0.001), indicating less DNA damage (Fig. 3.7A).  Similarly, in 
HSMC tail moment was lower in most groups including 3, 5, 7 and 9 h recovery following the 1 h 
0.2 mM H2O2 insult (p<0.0001) (Fig. 3.7B). At 3 h, the greatest change in DNA damage repair 
between two independent time-points was observed (damage at 3 h compared to 1 h), with tail 
moment decreasing by 38 AU in HAEC and 29 AU in HSMC. DNA damage can be visualized in 
HAEC (Fig. 3.7C) and HSMC (Fig. 3.7D) by the comet tail shape that appeared following H2O2 
insult, representative images show damage after 3 h recovery.  
The above findings suggested that NR delivery enhanced the efficiency of DNA repair in 
vascular cells. However, it remained possible that NR directly reduced the extent of initial oxidative 
injury. According to previous publications, sirtuins can upregulate the transcription of anti-oxidant 
genes (156-158). Therefore, I considered the possibility that NR reduced the initial absolute damage 
from oxidative insults, by activating the transcription of anti-oxidant genes. Interestingly, at 0 h 
recovery (immediately after the 1 h H2O2 incubation) the HAEC tail moment in NR-treated group 
was 108±3 AU, significantly lower than that in vehicle-treated control cells (130±5 AU, p<0.0001) 
(Fig. 3.7A) . This difference in tail moment at 0 h recovery in HAEC could be explained by either 
NR-enhanced DNA repair during the 1 h period of oxidative insult or the up-regulation of anti-
oxidant genes. Quantitative real-time PCR was used to determine NR’s impact on the regulation of 
transcript levels of selected anti-oxidant genes. Based on previous reports, I selected anti-oxidant 
genes downstream of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-
1α), a transcription coactivator known to be upregulated by SIRT1 (157). SIRT1 will bind and 
activate PGC-1α through deacetylation. I found no statistically discernible increase in PGC-1α, 
SOD1, SOD2, catalase and Prdx5 gene transcripts in either cell type following NR treatment (Fig. 
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3.8). In fact, in NR-treated HSMC, SOD1 showed a lower transcript level 70±10% of vehicle control 
expression and SOD2 showed 51±9%, indicating a subtle, but not significant, decrease in expression 
of a subset of anti-oxidant genes upon NR treatment (p=0.56 and p=0.68). Overall, these data provide 
evidence that NR does not increase the transcript levels of anti-oxidant genes. These results 
indirectly support that the reduction in oxidative stress-induced DNA damage by NR is attributed to 
enhanced DNA repair. Such enhanced DNA repair could be so efficient to have induced a noticeable 
difference as early as 0h, immediately after the cease of oxidative insult in HAEC.   
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Figure 3.7 NR promotes DNA repair. Comet assay kit, including alkaline agarose gel 
electrophoresis, was used to pull single- and double-strand DNA breaks from the nuclei of cells to 
form the characteristic comet tail. HAEC and HSMC, pre-treated with 0 or 100 μM NR for 24 h, 
were exposed to 0.25 mM or 0.2 mM H2O2, respectively, for 60 min and given 3-11 h recovery. Tail 
Moment (±SE) measured using Open comet analysis to evaluate impact of NR delivery on H2O2-
induced DNA damage on (A) HAEC (n=82-723) and (B) HSMC (n=79-542). *Pre-treatment with 
NR had significantly lower DNA damage, as measured by tail moment (see p. 78), than 
corresponding vehicle control group (p<0.05) using Two-Way ANOVA and Sidak’s Multiple 
Comparison Test of the means. (C-D) Representative images of comet tails with no treatment or 1 h 
H2O2 with 3 h recovery for (C) HAEC and (D) HSMC.  
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Figure 3.8 Anti-oxidant gene expression remains unchanged following NR delivery. (A) HAEC 
(n=6-9) and (B) HSMC (n=12) expression profile of anti-oxidant genes using SYBR Green 
Quantitative RT PCR. Primers for SOD1, SOD2, catalase, Prdx5 and PGC-1α were used to amplify 
mRNA following 24 h treatment with 100 μM NR. Values presented as ΔΔCt comparison of mRNA 
expression levels with NR treatment to vehicle control, standardized with 18s rRNA housekeeping 
gene. No significance determined by One-Way ANOVA and Tukey’s Multiple Comparison Test of 
the means.  
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3.8 NAD+ precursors NA, Nam and NMN similarly protect against H2O2-induced cell shrinkage 
and death. 
It has long been known that exogenous supplementation by NAD
+
 precursors, NA, Nam and 
NMN, will increase intracellular NAD
+
 levels in cell lines and tissue (250, 251). To determine if this 
NAD
+
 increase would mimic the protection observed by NR supplementation, HAEC and HSMC 
were incubated for 24 h with 100 μM NA, Nam and NMN and exposed to 4 hr H2O2.  I then tracked 
cells and assessed cell shrinkage using image J and viability using trypan blue exclusion. In HAEC, 
all three precursors significantly protected against H2O2-induced cell shrinkage at 4 h (NA p<0.0001, 
Nam p=0.002, NMN p=0.0005), although not at 2 h (Fig. 3.9A). In HSMC, NMN and Nam 
significantly protected against shrinkage at 4 h compared to baseline (p=0.003, p=0.005).  Only NA 
in HSMC exhibited a non-significant trend (p=0.16) (Fig. 3.9C). There were no differences observed 
in viability in HAEC (NA p=0.49, NMN p=0.96, Nam p>0.99) (Fig. 3.9B). A subtle trend towards 
increased viability was observed for precursor supplementation in HSMCs, although differences 
were not significant (NA p=0.76, NMN p=0.46, Nam p=0.85) (Fig. 3.9D). 
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Figure 3.9 NAD+-precursors similarly protect vascular cells from H2O2-induced cell shrinkage. 
HAEC and HSMC, pre-treated with NA, Nam or NMN for 24 h, were exposed to 0.25 mM H2O2 and 
0.2 mM H2O2, respectively, and imaged through time-lapse Hoffman contrast microscopy for 4 h. 
Fold change in area (±SE), measured by tracking cells and tracing border in Image J, was recorded 
for (A) HAEC (n=44-48) and (C) HSMC (n=48).  Trypan Blue exclusion viability data (±SE) was 
collected 4 h post-insult for (B) HAEC (N=3) and (D) HSMC (N=3). * Shows significantly less cell 
shrinkage at 4 h only, compared to cells not treated with precursors (p<0.05) using Two-Way 
ANOVA and Tukey’s Multiple Comparison Test of the means. 
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3.9 PARP inhibition maintains NAD+ levels to promote morphology and viability, but impairs 
DNA repair responses.  
Demonstrated by my data, NR will create NAD
+
 reserves that support beneficial stress 
response pathways during times of profound oxidative burden. Building on this principle, blocking 
NAD
+
 consumption to maintain NAD
+
 levels during oxidative stress insults should similarly 
demonstrate beneficial effects. These NAD
+
 reserves should maintain sirtuin function and ATP 
production to fuel stress response pathways. As described above, PARP family of enzymes are a 
major consumer of NAD
+
, thus PARP inhibition through DPQ treatment was tested to determine 
protection from H2O2-induced changes in morphology, viability and DNA integrity.  
To determine if DPQ will protect against H2O2-induced cell-shrinkage and viability, HAEC 
and HSMC were pre-treated with 1 hr DPQ and exposed to 4 hr H2O2 insult.  This revealed that 
PARP inhibition mimicked NR’s beneficial effects on both cell shrinkage and viability. At both 2 
and 4 h after H2O2 treatment, DPQ-treated HAEC showed significantly less cell shrinkage 
(p<0.0001) compared to DMSO vehicle control (Fig. 3.10 A). Furthermore, HAEC pre-treated with 
DPQ had almost two-fold higher viability (p<0.0001) compared to DMSO vehicle control (Fig. 
10B).  Similarly, HSMC displayed significantly less cell shrinkage at 2 h (p=0.009) and 4 h 
(p=0.0002) with DPQ treatment compared to DMSO vehicle control (Fig. 3.10C). Additionally, 
viability in HSMC following H2O2 with DPQ treatment was 81±7%, significantly higher that DMSO 
vehicle control of 56±9% (p=0.02) (Fig. 3.10D).  
In contrast to its benefits over cell morphology and viability, I found that PAPR inhibition 
delayed DNA repair. This was most evident at 3 h, where HAEC pre-treated with DPQ had 33%  
higher tail moment and HSMC had 45% higher tail moment compared to vehicle control (p<0.0001) 
(Fig. 3.10 F&H). DNA damage can be visualized by the comet tail shape that gradually loses length 
and intensity as DNA breaks are repaired during recovery. Representative 3 h and 11 h recovery 
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images are shown (Fig. 3.10 E&G). DNA remains localized within the confines of the nuclei of 
untreated cells. DPQ pre-treatment attenuates DNA break repair, shown by longer, more intense 
comet tail and smaller, less intense comet head at 3 h as compared to DMSO vehicle pre-treatment. 
These findings are consistent with the fact that PARP functions to catalyze PAR chains on itself, 
histones and non-histone proteins to recruit DNA repair machinery to the site of damage.  PARP 
inhibition does not mimic the beneficial effects observed by NR delivery because it attenuates DNA 
repair.  
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Figure 3.10 PARP inhibition mimics beneficial effects of NR, but at the cost of DNA repair 
efficiency. HAEC and HSMC were pretreated 1 h with DPQ and incubated for 4 h with 0.25 mM 
H2O2 and 0.2 mM H2O2, respectively, and imaged with time-lapse Hoffman modulated contrast 
microscopy for 4 h.  (A) HAEC fold change in area (±SE, n=80-112) and (C) HSMC (±SE, n=80-
96), measured by tracking cells and tracing their borders in Image J. There is less cell shrinkage at 4 
h in cells pre-treated for 1 h with 20 μM DPQ. Viability data based on trypan blue exclusion, 
corresponding to 4 h time point of time-lapse videos showing attenuated cell death upon DPQ 
delivery in (B) HAEC mean (±SE) (N=5) and (D) HSMC mean (±SE) (N=6) . Vehicle control group 
for 0.25 mM H2O2 + 0.8% DMSO showed no difference compared to 0.25 mM H2O2 for both cell 
shrinkage and viability (data not shown). *Pre-treatment with DPQ showed significantly higher 
viability and less shrinkage than corresponding vehicle control group (p<0.05, using Two-Way 
ANOVA and Tukey’s Multiple Comparison Test of the means).  Comet assay kit, including alkaline 
agarose gel electrophoresis, was used to pull single- and double-strand DNA breaks from the nuclei 
of cells to form the characteristic comet tail shape. HAEC, pre-treated with 0 or 20 μM DPQ for 1 h, 
were exposed to 0.25 mM H2O2 for 30 min and given 3-11 h recovery.  In (E) HAEC and (G) HSMC 
DNA damage can be visualized by the comet tail shape that gradually loses length and intensity as 
DNA breaks are repaired during subsequent recovery, 3 h and 11 h shown. DNA remains localized 
within the confines of the nuclei of untreated cells. DPQ pre-treatment attenuates DNA break repair. 
Tail Moment in (F) HAEC (±SE) (n=475-816) and (H) HSMC (±SE) (n=738-959) measured using 
Open comet analysis to evaluate impact of DPQ delivery on H2O2-induced DNA damage. *Pre-
treatment with DPQ had significantly higher DNA damage, as measured by tail moment, than 
corresponding vehicle control group (p<0.05, using Two-Way ANOVA and Sidak’s Multiple 
Comparison Test of the means). 
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3.10 Role of the sirtuin family of enzymes in oxidative stress responses.   
I next speculated that the augmentation of NAD
+
 reserves offered by NR might increase the 
activity of NAD
+
-consuming enzymes such as sirtuins. These histone deacetylases consume NAD
+
 to 
regulate transcription of targets implicated in many cellular functions (245). Thus, I hypothesized 
that the observed NR protective effects may, in part, be attributed to sirtuins. The involvement of 
SIRTs 1-7 was independently assessed with respect to morphology, viability and DNA repair using 
siRNA against SIRTs 1-7. The objective of this experiment was to build a molecular pathway to 
explain NRs observed protection beyond providing NAD
+
 reserves themselves.  
First I determined that SIRT knockdown (KD) could be obtained by siRNA against SIRT 1-7 
in vascular cells. HAEC and HSMC were incubated for 48 h with Lipofectamine RNAi max and 
siRNA against respective SIRTs.  KD efficiency was then confirmed through real-time PCR. Upon 
transfection with gene-specific siRNAs,  transcript levels were reduced to 30% or lower, as 
compared with scrambled negative control siRNA, for all SIRTs in both cell types, except SIRT3 
(Fig. 3.11 A&B). Expression of SIRT3 was reduced to 35±3% in HAEC and 42±6% in HSMC.  
Next, I wanted to reproduce NRs protection against cell shrinkage and cell death and NRs 
ability to promote DNA repair, but now under conditions of scrambled negative control siRNA 
treatment (siscram). This would confirm that procedure of siRNA delivery was not altering NRs 
beneficial effects. To answer this, I incubated cells with 48 h Lipofectamine RNAi max and 
scrambled negative control siRNA and pre-treated for 24 h with NR or vehicle.  To determine NRs 
protection against cell shrinkage and cell death, cells were exposed to 4 h H2O2 and cell area changes 
and viability were assessed. This revealed that in HAEC and HSMC siscram with NR compared to 
siscram without NR had significantly less cell shrinkage (p=0.007, p=0.04) and significantly higher 
viability (p=0.0007, p=0.003) (Fig. 3.12). To determine NRs ability to promote DNA repair, tail 
moment was assessed at 3 h after cells were exposed to 1 h H2O2. This time-point was chosen 
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because it represented the largest change in damage (between 1 h and 3 h time-points, as seen in Fig. 
3.7), thus it offered the most information when assessing impact of interventions on promoting 
repair. In both HAEC and HSMC, tail moment was significantly less in siscram with NR compared 
to siscram with vehicle (p<0.0001) (Fig. 3.11). Significant differences between siscram with and 
without NR confirmed that the procedure of siRNA delivery was not altering NRs beneficial effects.  
Next, to determine the role of SIRT 1-7 in NRs ability to promote DNA damage repair, cells 
were incubated with siRNA against one of SIRT 1-7 and then pre-treated with NR for 24 h. Tail 
moment analysis data for each SIRT KD with NR was then compared to siscram with NR and 
siscram with vehicle to determine partial, full or not abolished NR protection. If tail moment of SIRT 
KD with NR was significantly higher than siscram with NR, protection was at least partially 
abolished. If tail moment of SIRT KD with NR reached a level that was not statistically different 
from siscram with vehicle, this was considered full loss of protection. This rationale was used in Fig. 
3.11 to report the effect of each SIRT KD on NRs ability to promote DNA repair. Analysis of tail 
moment at 3 h post 1 h H2O2-insult revealed partial loss of NRs protection for KD of all SIRT 1-7 in 
HAEC (Fig. 3.11C) and only SIRT1, SIRT3 &SIRT6 in HSMC (Fig. 3.11D). Data is summarized in 
a chart displaying mean values ±SE and p-values. From these charts, data for siscram with and 
without NR, SIRT1 and SIRT6 were displayed in a bar graph with respective controls (Fig. 3.11 
E&F).  
Finally, to determine the role of SIRT 1-7 in NRs ability to protect against cell shrinkage and 
death, cells were incubated with siRNA against one of SIRT 1-7 and then pre-treated with NR for 24 
h. Cells were then subjected to 4 h H2O2 and change in area and viability was assessed. This data was 
similarly summarized using a chart to report on the full profile of SIRT KD, and a graph is shown 
representing SIRT1 and SIRT6 data specifically (Fig. 3.12). KD of SIRT 1-7 with NR is compared to 
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siscram with vehicle, to determine if NRs protection is lost, indicated by no significant difference to 
siscram with vehicle. Cell shrinkage data revealed that all of the SIRT 1-7 KD with NR treatments 
were significantly different than siscram with vehicle, suggesting NR protection remains (Fig. 
3.12A). However, HSMC showed cell shrinkage return to the level of siscram with vehicle in SIRT 
1, SIRT2, SIRT3 and SIRT7 KD with NR (Fig. 3.12B).Viability levels returned to siscram with 
vehicle in HAEC for SIRT1, SIRT2 and SIRT6 KD with NR (Fig. 3.12E) and in HSMC for SIRT1, 
SIRT2, SIRT3 and SIRT6  KD with NR (Fig. 3.12F). When damage returned to levels of siscram 
with vehicle, NRs protection was considered to be abolished.   
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Figure 3.11 Role of Sirtuin family of enzymes in DNA damage response.  (A) HAEC (n=3) and 
(B) HSMC (n=3) expression profile of sirtuin genes using SYBR Green Quantitative RT PCR. 
Primers for sirt 1-7 were used to amplify mRNA following 48 h incubation with Lipofectamine 
RNAi Max reagents and respective siRNA. Values presented as ΔΔCt comparison of knockdown 
mRNA to scrambled siRNA control, standardized with 18s rRNA housekeeping gene. (C) HAEC 
and (D) HSMC were exposed to 1 h H2O2 and given 3 h recovery time before analysis with alkaline 
comet assay. The profile of sirtuin gene KD was pre-treated with 100 μM NR for 24 h and compared 
to scrambled siRNA with and without NR treatment. Partially abolished NR protection refers to tail 
moment significantly different than siscram both with and without NR. No abolished protection 
refers to tail moment not significantly different than siscram with NR treatment.  Tail moment (±SE) 
of siscram, SIRT1 KD+NR and SIRT6 KD+NR groups from (C&D) were graphed with respective 
controls in (E) HAEC (n= 273-482) and (F) HSMC (n=613-765 ). Groups with the same letter are 
not significantly different from each other using One-Way ANOVA and Dunnett’s Multiple 
Comparison Test of the means (p<0.05).  
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Figure 3.12 Sirtuins mediate NR's protection against H2O2-induced cell shrinkage and cell 
death in vascular cells. SIRT 1-7 knockdown was achieved by 48 h incubation with Lipofectamine 
RNAi Max reagents and respective siRNA. (A) HAEC (n=80-108) and (B) HSMC (n=64) fold 
change in area at four h compared to baseline, measured by tracking cells and tracing border in 
Image J. (E) HAEC (n=7) and (F) HSMC (n=7) viability quantified by trypan blue exclusion. No 
significant differences compared to siscram without NR, suggests abolished NR protection (p<0.05) 
using One-Way ANOVA and Dunnett’s Multiple Comparison Test of the means. (C,D,G,H) Bars in 
red were pre-treated for 24 h with 100 μM NR and blue bars correspond to vehicle control. Dotted 
line separates groups exposed to 0.25 (HAEC) and 0.2 mM (HSMC) for 4 h, from untreated controls. 
Fold change in area (±SE) of siscram, SIRT1 KD+NR and SIRT6 KD+NR groups from (A&B) were 
graphed with respective controls in (C) HAEC and (D) HSMC. Viability (±SE) of siscram, SIRT1 
KD+NR and SIRT6 KD+NR groups from (E&F) were graphed with respective controls in (G) 
HAEC and (H) HSMC. Groups with the same letter are not significantly different from each other 
using One-Way ANOVA and Dunnett’s Multiple Comparison Test of the means (p<0.05). 
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3.11 NR delivery protects vascular cells from chronic H2O2-induced senescence, in a partially 
SIRT1 and SIRT6 dependant manner. 
Previous studies have reported SIRT1 implicated in age-associated senescent phenotype in 
vascular endothelial cells (141-144). Similarly, SIRT6 deficiency has been linked to oxidative stress-
induced senescence in endothelial cells (180). In Fig. 3.11 and 3.12, it was revealed that NR acts 
through SIRT1 and SIRT6 dependent pathways to protect against cell shrinkage, cell death and 
promote DNA repair. Additionally, accumulation of DNA damage is a key factor in acquiring a 
senescent phenotype. I therefore speculated that it was possible that NR may protect against 
senescence in SIRT1 and SIRT6 dependent pathways. The previous acute H2O2 dose induced high 
levels of cell death, which would compound the interpretation of cellular senescence of surviving 
population. Therefore I selected a milder H2O2 insult (25 and 20 μM for HAEC and HSMC, 
respectively, 1/10 of the dose for cell death and DNA damage insults). This more chronic oxidative 
insult would also be more relevant to an aging model. 
To determine if NR protected against senescence in vascular cells, I used senescence-
associated β galactosidase (SA β-Gal) activity assay, a blue colorimetric assay. To assess NR's effect 
on cell senescence, I pre-treated cell with 100 μM NR for 24 h and subjected them to 1 h H2O2. At 48 
h following H2O2 insult, fewer SA β-Gal positive blue cells were observed in both vascular cell types 
incubated with NR compared to vehicle (Fig. 3.13 A&B).  
Image J was then used to quantify percent positive cells per field of view. Quantification of 
SA β-Gal positive cells at 48 h following H2O2 treatment revealed significantly higher levels than 
baseline (HAEC p=0.009, HSMC p=0.001) (Fig. 3.13C,D). Pre-treatment with NR significantly 
protected against oxidative-stress-induced senescence. Specifically, HAEC vehicle control showed 
41±2% positive cells following H2O2 insult, with protection by NR showing only 24±3% positive 
cells (p=0.007) (Fig. 3.13C).  HSMC vehicle control showed 35±3% positive cells following H2O2 
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insult, and significantly less senescence of  22±3% positive cells in group pre-treated with NR 
(p=0.039) (Fig. 3.13 D). 
To determine if SIRT1 and SIRT6 were implicated in NRs protection against H2O2-induced 
senescence, I used SA β-Gal staining. Cells were exposed to 48 h incubation with Lipofectamine 
RNAi Max and siRNA against SIRT1 and SIRT6 and pre-treated for 24 h with NR or vehicle.  Sirt1 
or Sirt6 KD with NR revealed a not significant but noticeable increase in senescent cell population 
compared to H2O2-treated cells with vehicle.  Interesting, without NR-treatment, Sirt1 and Sirt6 KD 
increased % positive cells to levels above H2O2-treated cells with vehicle in HAEC, however this 
difference was not significant (SIRT1 & SIRT6, p=0.1) These finding suggested a protective role of 
NR against cellular senescence induced by chronic, non-lethal oxidative stress, and that protection by 
NR is partially mediated through SIRT1 and SIRT6.  
Next, to complete the comparison of NR delivery versus PARP inhibition, I determined if 
PARP inhibition would protect against senescence. To answer this, I pre-treated cells for 1 h with 20 
μM DPQ and subjected cells to 1 h H2O2. At 48 h after H2O2 insult, no significant difference was 
observed in cells incubated with PARP inhibitor (DPQ) compared to H2O2-treated group with vehicle 
in both cell types (HAEC & HSMC p=0.99) (Fig. 3.13 C&D). This suggests that PARP inhibition 
and associated NAD
+
 reserve, despite eliciting a similar rescuing effect on cell morphology and 
viability, could not protect against H2O2-induced cell senescence.   
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Figure 3.13 DPQ and knockdown of SIRT1 or SIRT6 partially abolish NR’s protection against 
H2O2-induced senescence. Representative images of senescence –associated β Gal staining in (A) 
HAEC and (B) HSMC 48 h after 1 h 0.025 and 0.02 mM H2O2 insult, respectively. Pre-treatment 
with 100 μM NR or no treatment (NT) for 24 h protects against senescence, visible through fewer 
positive blue cells in both vascular cell types. Quantification of positive senescence-associated β Gal 
in (C) HAEC (n=6-20) and (D) HSMC (n=12), analyzed percent positive cells in fields of view using 
Image J. Cells were pre-treated with 20 μM DPQ, 48 h Lipofectamine RNAi Max reagents & siRNA 
against SIRT1 or SIRT6, and/or 24 h 100 μM NR. Groups with the same letter are not significantly 
different (p<0.05) using One-Way ANOVA and Dunnett’s Multiple Comparison Test of the means. 
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4 – DISCUSSION 
The major findings of this thesis are summarized: 
1.  Abundance of Nrk1, a critical enzyme responsible for NR conversion in NAD+, is 
upregulated in vivo under conditions of NAD
+
 pathway deficiencies in brain, aorta and heart. 
2. The human vascular cell lines, HSMC & HAEC, express Nrk1 and NR delivery lead to a 
dose-dependent increase in cellular NAD
+
 content. 
3. Oxidative stress insults induced oxidative DNA lesions and activated PARP, resulting in 
pronounced NAD
+
-consumption in vascular cells. 
4. NR delivery generated NAD+ reserves that buffered PARP-mediated NAD+ consumption 
during oxidative insults in vascular cells. 
5. NR delivery preserved viability and morphology and promoted DNA repair following 
oxidative stress insult in vascular cells. 
6. PARP inhibition generated NAD+ reserves by blocking consumption. This preserved viability 
and morphology, but at the cost of impaired DNA damage repair. 
7. NR delivery preserved viability, protected against senescence and promoted DNA repair in 
vascular cells with partial support for SIRT1- and SIRT6- dependent pathways. 
4.1 Potential of NR Delivery in Vascular Aging 
Vascular pathology and inflammation, arising predominantly in aged vasculature, is 
associated with chronic oxidative stress (65, 226-228). Current interventions are limited and involve 
pronounced lifestyle changes in diet and physical activity, which can be challenging. There is 
growing appreciation for the impact of NAD
+
 biology in aging, in part because of increased oxidative 
stress induces NAD
+ 
depletion (194-196). There are molecular pathways that may be contributing to 
these observed changes, including (1) PARP activation, (2) declining NAMPT expression, and (3) 
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relative nutritional deficiencies.  Notably, all of these pathways centre on vulnerability of NAD
+
 
supply systems in aged tissues. NR delivery is an emerging intervention to combat this NAD
+
 
deficiency.  
In this study I have shown that human vascular endothelial and smooth muscle cells are 
equipped with the necessary systems to bring NR into the cell and metabolize NR into NAD
+
. 
Vascular cells were able to stably increase intracellular NAD
+
 levels. NR delivery is an emerging 
field and the limited current reports have assessed NR delivery to stably increase intracellular NAD
+
 
pools in yeast, mouse myoblast, mouse heptoma and human embryonic kidney cell lines (202, 233). 
This is the first report to my knowledge that assesses NR delivery in vascular cells.  
Additionally, I have found that mouse aorta, comprising endothelial and smooth muscle cells, 
also expressed Nrk1.  Further, under NAD
+
 deficient conditions, characteristic of aged tissue, my 
preliminary data showed that mouse aorta upregulated Nrk1, independent of changes to other NAD
+
 
salvage enzymes. This suggests that NR delivery may be a preferred pathway to overcome depleted 
NAD
+
 supply in vascular tissues. Previous reports have identified tissue-specific differential 
expression of NAD
+
 salvage enzymes (204). Here, we expand the tissue profile to include aorta and 
confirm expression of Nrk1. Previous studies in yeast have noted an increased uptake of NR when 
other precursors are not available (202). Our findings build on this concept and identify selective 
upregulation of Nrk1 mRNA expression under NAD
+
 deficient conditions that we speculate may 
facilitate NR uptake in the vasculature. Importantly, my findings set the stage for NR delivery in a 
vascular aging model. 
4.2 Intracellular NAD+ Pools Fuel Oxidative Stress Response 
 This study established that H2O2 induced oxidative DNA lesions in vascular cells. This was 
associated with PARP activation and profound NAD
+
 consumption, in a PARP dependent manner. 
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Further, we show that PARP inhibition will maintain NAD
+
 levels, protect against viability, but also 
preserve morphology in vascular cells exposed to an acute oxidative stress insults. The role of PARP 
as a major NAD
+
 consumer in response to oxidative damage has been previously established (111). 
Recognizing the link between NAD
+
 consumption and cell death, PARP inhibition studies have 
emerged reporting protection in models of acute DNA damage caused by chemotherapy drugs (121-
123) and ischemia/reperfusion injury (252, 253). In these models, protection can be explained by 
PARP inhibition preserving NAD
+
 levels, thereby preventing an energy crisis and maintaining SIRT 
function during times of stress.  My data supports the principle that maintaining NAD
+
 levels will 
prevent an energy crisis and protect against cell death. Expanding on this, my data also introduced 
the concept that PARP inhibition preserves cell morphology.  
 This study further demonstrated that the beneficial effects of increasing NAD
+
 reserves can 
be obtained by NR delivery. My data showed that NR delivery elevated NAD
+
 levels, protected 
against cell death, preserved cell morphology, and importantly increased DNA repair efficiency. 
Further, NR was observed to protect against H2O2-induced senescence.  This data supports that NR 
generated NAD
+
 reserves will fuel PARP function while maintaining NAD
+
 levels above an energy 
crisis threshold (Fig. 4.1). Supplementation of other NAD
+
 precursors (NA, NMN and Nam) was 
observed to mimic the effects of NR delivery on maintaining cell shape in these vascular cells. This 
finding further supports that the benefits of NR delivery are acting through increased intracellular 
NAD
+
 pools.  
My data supports that PARP inhibition, NR delivery, and delivery of NAD
+
 precursor 
supplementation will increase NAD
+
 supply to protect against oxidative stress insult. As discussed 
below, I propose that, of these approaches, NR delivery is superior.  
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Figure 4.1 NR fuels PARP function to support DNA repair during oxidative insults. NR 
increases intracellular NAD
+
 stores to facilitate cellular oxidative stress response. PARPs consume 
NAD
+
 to catalyze PAR chains, which act to recruit downstream repair proteins. When NAD
+
 levels 
are depleted beyond a threshold, an energy crisis ensues. Similarly, if NAD
+
 levels are not sufficient 
to maintain PARP function or PARP is inhibited, cells may survive but are more likely to take on a 
senescent phenotype.   
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4.3 Limitations to PARP Inhibition 
Importantly, this study directly addresses the limitations of PARP inhibition. PARP is 
activated in response to DNA damage to recruit repair enzymes to the site of damage (111). My data 
reveals that PARP inhibition will delay DNA repair in vascular cells. Additionally, I found that 
PARP inhibition did not prevent a senescent phenotype following oxidative stress insults. Thus 
PARP inhibition supports the rationale for increased NAD
+
 reserves, but benefits of its intervention 
are short-term and restricted to acute models.  
Since PARP is a nuclear enzyme, it is speculated that this intracellular NAD
+
 increase is 
confined mostly to the nucleus and thus will likely effect only the SIRTs that reside there (SIRT1, 
SIRT6 and SIRT7). However, NR delivery has the potential to increase intracellular NAD
+
 levels in 
additional subcellular compartments such as mitochondria (SIRT3, SIRT4 and SIRT5) and 
cytoplasm (SIRT1, SIRT2 and SIRT3) (254). A series of recent reports support this concept of 
confined subcellular NAD
+
 pools. One report revealed that PARP-1 inhibition increased SIRT1 
activity levels but not SIRT3, thereby increasing energy expenditure and protecting and against 
metabolic disease (255). Additional studies reported beneficial effects of NR delivery through SIRT3 
activity in metabolic disease (233) and hearing loss (234). This supports the concept that NR delivery 
may have broader effects of increasing NAD
+
 pools compared to PARP inhibition that may be 
confined to the nucleus. My data showed that despite beneficial effects that PARP-1 inhibition may 
have through nuclear SIRT activation, the consequences of impaired DNA repair response dominated 
in this oxidative stress model.   
4.4 NR as a Superior NAD+ Precursor 
Despite benefits of other NAD
+
 precursors on preserving cell morphology, there are 
advantages to NR delivery. First, only NR is a nutrient that is naturally present within the human diet 
107 
 
 
 
(216). Additionally, NR does not activate GPR109A, a niacin receptor, associated with NA-mediated 
painful flushing (229, 230). NMN is degraded outside of the cell and brought in as either NA, or NR, 
creating an additional step for up-take (201). Finally, Nam is a known SIRT inhibitor (256). 
Consequently, although NAD
+
 precursors can similarly elevate NAD
+
 levels, NR offers advantages 
over other NAD
+
 precursors. 
4.5 NR-mediated SIRT Activation in DNA Damage and Repair 
As discussed, NR delivery may offer a more advantageous approach to increase intracellular 
NAD
+
, increase sirtuin activity and thereby enhance oxidative stress response throughout the whole 
cell. My data showed that NR enhanced the DNA repair response.  Through KD studies, I implicated 
a number of SIRTs in this effect. The identified involvement of SIRTs from various subcellular 
compartments supports the idea that NR has the ability to broadly increase intracellular NAD
+ 
levels. 
In both cell types, SIRT1 and SIRT6 were implicated in NR-mediated DNA repair. Both of 
these SIRTs have downstream DNA repair targets (254). To my knowledge, no previous studies have 
directly looked at benefits of NR delivery in mediating DNA repair efficiency. However, one recent 
report found that both PARP inhibition and NR delivery were observed to overcome 
neurodegeneration-associated phenotypes induced by mutations to DNA repair proteins. 
Interestingly, this study looked at NRs effect on normalizing the transcriptome of diseased mice and 
found that NR normalized gene ontology terms for DNA damage repair, DNA damage response and 
oxidative stress. Additionally, a few studies have reported the role of SIRT1 (151, 153, 154, 165, 
166) and SIRT6 (169-171) in promoting DNA repair. These reports may offer support for my data, 
which demonstrated NR-mediated DNA repair efficiency in a partially SIRT1 and SIRT6 dependent 
manner. 
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In addition to changes in the DNA repair response, SIRT1, 3, 5 and 6 have downstream 
targets on anti-oxidant machinery (257). Specifically, previous reports have identified SIRT1 as a 
regulator of anti-oxidant gene transcription in vascular endothelial cells (157, 158). A single study in 
human embryonic kidney cells did report an increase in SOD2 mRNA expression following NR 
delivery (233). However, my data showed that NR delivery did not induce transcriptional changes of 
anti-oxidant genes.  Additionally, changes in transcription do not always mean changes in protein 
translation or activity, which were not assessed in this thesis.  
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Figure 4.2 Increased SIRT1 & SIRT6 activity may enhance NRs protection through improved 
defence systems and repair responses. Intracellular NAD
+
 reserves will fuel NAD
+
-consuming 
SIRT activity. SIRT1 and SIRT6 have been reported to target regulators of anti-oxidant genes 
transcription and directly target enzymes involved in DNA repair. During times of oxidative stress, 
both of these pathways would contribute to improved outcomes with respect to maintaining genome 
integrity and evading senescence.  
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4.6 SIRT Involvement in Enhanced Viability  
We observe improved cell viability with PARP inhibition and NR delivery following acute 
oxidative damage. I interpret these viability experiments in the context of an NAD
+
-consumption 
model. Through NR delivery, or PARP inhibition, NAD
+
 levels are maintained above an energy 
crisis threshold while cells continue to consume NAD
+
 in their response to the oxidative stress insult.  
In this study, I also revealed that NR-mediated protection from cell death was partially lost 
when SIRTs were knocked-down. Accordingly, an additional interpretation to explain protection 
from cell death is that NR and PARP inhibition increased NAD
+
 levels and activated SIRT1 to 
partially promote viability. SIRT1 will deacetylate downstream targets such as FOXOs, which can 
signal for cell survival and promote stress responses (140). The deacetylation activities of SIRT1 
have also been reported to increase autophagy (130). By inducing autophagy, the catabolic process to 
break-down inefficient organelles, additional energy stores are created and cellular energy 
metabolism is enhanced by healthier mitochondria (258).  Both of these pathways could explain why 
NR protection from cell death was found to be partially SIRT1-dependent in both vascular cell types.  
4.7 Role of SIRTs in Maintaining Cytoskeleton Integrity 
 Our data showed that NR supported cell morphology during times of oxidative stress by 
preventing cell shrinkage.  Actin structures are essential to cell shape and our closer look at actin 
structures during the oxidative insult support the concept that NR supplementation maintains 
cytoskeleton integrity.  
This link between NR enhancing actin structures has not yet been established. NR may be 
acting through anti-oxidant up-regulation to protect the cytoskeleton during the oxidative insult; 
however this concept was not fully explored in this thesis. Downstream target of sirtuins that regulate 
actin structures have not been well studied. 
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4.8 Implications of SIRTs in Vascular Aging 
I found that SIRT1 and SIRT6 were observed to be abundantly expressed in aorta tissue. I 
also found that SIRT1 and SIRT6 were implicated in NR-mediated DNA repair in both cell types and 
protection to viability in HAECs. Importantly, by also studying senescence, I examined oxidative 
stress response in a model arguably more relevant to vascular aging compared to acute cell damage. 
Within this model, SIRT1 and SIRT6 were again implicated in NR’s protection against senescence. 
This is consistent with previous literature that has implicated SIRT1 in preventing senescence and 
sirt6 decline associated with increased senescence (180, 259). In addition to expanding NR delivery 
interventions to include vascular tissues, we have shown that NR delivery will act through these two 
identified SIRTs to regulate vascular cell health during oxidative stress.  
4.9 Limitations 
My study revealed no changes in anti-oxidant gene expression following NR delivery. 
However, their potential involvement should not be ruled out. For my experiments, real-time PCR 
was used to analyze a small subset of the entire expression profile. A far more complete approach 
would be transcriptome sequencing and even this approach requires careful interpretation since data 
is compositional (constrained to relative values). Further, changes in transcription do not always 
mean changes in translation or activity, which would additionally need to be assessed. 
SIRT-mediated changes in anti-oxidant gene regulation and cytoskeleton changes assume that 
higher NAD
+
 levels are increasing SIRT activity. Currently, interpretations of downstream effects of 
SIRTs are based on this assumption. Support for NR-mediated increase in SIRT activity is currently 
limited. Two previous NR studies that observed beneficial effects of NR delivery reported SIRT-
dependent mechanisms (233, 234). Only one of those two studies directly looked at SIRT1 and 
SIRT3 activity changes following NR delivery in human embryonic kidney cells (233). To overcome 
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this limitation, SIRT activity assays would be required to confirm that SIRT activity is increased in 
response to NR in human vascular cells. 
Interpretation of SIRT KD with NR in determining if NR protection is abolished is limited by 
the fact that SIRTs themselves consume NAD
+
. By inhibiting their NAD
+
 consumption through KD, 
the interpretation is complicated by the possibility that SIRT KD alone is increasing NAD
+
 levels.  
However, according to my results, higher NAD
+
 levels should promote viability and DNA damage 
repair. Instead, I found that SIRT KD with NR delivery showed increased cell death and higher tail 
moment. Ultimately this implicates SIRT KD in detrimental effects on viability and DNA damage 
repair, despite any benefits that may be induced by additional NAD
+
 supply.  
Currently, interpretation of DNA damage repair experiments is confounded by potential 
differences in initial DNA damage insults. If NR delivery induced differences in anti-oxidant 
expression, NR-treated groups may have started with lower absolute DNA damage. This limitation 
could be overcome by using DNA damaging agents (doxorubicin, methy-methane sulphonate or 
paraquat) to induce DNA strand breaks instead of H2O2. This would eliminate any role that anti-
oxidants may be playing and instead allow for interpretation of solely DNA damage repair. 
Chronic vascular models such as atherosclerosis (120), ANGII infusion (124) and 
hypertension (115, 125) have been reported to benefit by PARP inhibition. PARP inhibition-induced 
beneficial effects in these models may be explained by blocking deleterious effects of down-stream 
PAR signalling, which has been associated with increased inflammation, oxidative stress and cell 
death (260). In our model of generating NAD
+
 to fuel PARPs in a chronic setting, the adverse 
consequences of increased PAR signalling are not addressed.  However, the final experiment of this 
study did show that NR was able to protect against H2O2-induced senescence whereas PARP 
inhibition was not. Additionally, my data suggests that NR may be acting partially through SIRTs. 
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Although the downstream SIRT-dependent pathways were not explored in this thesis, reduced 
oxidative damage or activated stress response pathways may have mitigated the deleterious effects of 
PAR chain formation.  
4.10 Future Directions 
Mode of cell death differences, following H2O2 stress, between NR-treated cells and vehicle 
control was not considered. Likely, a form of necrosis is occurring, initiated by an energy crisis 
following profound NAD
+
 consumption (114, 119). More specifically, parthanatos may be occurring. 
Parthanatos is a necrotic mode of cell death, characterized by profound nuclear PAR chain 
accumulation, translocation of PAR to the mitochondria and release of apoptosis initiating factor 
(AIF). It is possible that NR is enabling a subset of cells to resist necrosis and instead initiate a mode 
of cell death less damaging to surrounding cells, such as apoptosis or necroptosis. Determination of 
necrosis versus apoptosis would be possible through a cell death kit using Ethidium Homodimer III 
to signal necrosis and Annexin-V on the plasma membrane to signal apoptosis. Additional mode of 
death considerations would include TUNEL assay, assessing DNA fragmentation, or Western blot of 
the caspase family of enzymes, to determine if cell death is caspase-dependent.  
Additional cytoskeletal structures may be maintaining morphology during oxidative insults. 
Tubulin will act to maintain cell shape, but they also form networks for intracellular organelle and 
protein transport (261). Dynamic instability is crucial to tubulin function, as it will polymerize and 
de-polymerize continuously to transport across the cell.  Post-translational modification, such as 
acetylation, is one regulator of tubulin dynamics. SIRT2 has been reported to deacetylate α-tubulin, 
in an NAD
+
 dependent manner (262, 263). Changes in SIRT2 activity have been linked to altered 
microtubule dynamics (264). Further, agents that alter tubulin-mediated intracellular transport of 
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DNA repair proteins worsen DNA damage repair (265). Thus, an interesting next step would be to 
observe if NR is acting through SIRT2 to regulate cell shape and DNA repair via tubulin regulation. 
Additionally, to strengthen the interpretation of the effects of SIRT KD on NRs protection to 
viability, cell shrinkage and tail moment end-points, an additional control of SIRT 1-7 KD without 
NR should be added. This would strengthen the argument that increased cell death and higher tail 
moment as a result of SIRT KD with NR is in fact demonstrating abolished NR protection. Currently, 
it is possible that SIRT KD is causing detrimental effects through a distinct pathway, occurring in 
parallel to NR-mediated signalling pathways. 
My encouraging in vitro results have led to the design of in vivo experiments in our lab. The 
over-activation of the renin-angiotensin system has been associated with normal aging (85-88). 
Because of this, delivery of exogenous ANGII could be used to model age-associated changes of the 
vasculature in vivo. On a molecular level, ANGII will induce oxidative stress through eNOS 
uncoupling (92) and NAD(P)H oxidase activation (93, 94). Thus, ANGII infusion offers an in vivo 
model for oxidative stress insults. Experimental design for next steps was determined. Middle aged 
mice will be given NR (400 mg/kg/day) or vehicle control for seven weeks, including a three week 
pre-treatment with NR. Following this pre-treatment, oxidative stress will be induced by 4-weeks 
continuous ANGII infusion (1.44 mg/kg/day). Acting on evidence of enhanced oxidative stress 
response in vascular cells, this project will include an analysis of 8-oxoganine staining in the arteries 
of the heart of NR pre-treated mice following ANGII infusion. This study is currently underway and 
preliminary data are being generated.  
4.11 Conclusion  
In summary, I have found that PARP will consume NAD
+
 to recruit repair proteins to the site 
of oxidative-stress-induced DNA damage. Through this pathway, depleted NAD
+
 levels as a result of 
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PARP activity are speculated to contribute to vascular dysfunction in aging (65). My findings 
suggest that NR delivery will generate NAD
+
 reserves to fuel oxidative stress responses. These 
NAD
+
 reserves maintain PARP function during times of stress, but importantly continue to fuel SIRT 
function and energy metabolism. This intervention has the potential to overcome age-associated 
NAD
+
 supply deficiencies to combat chronic oxidative stress insults.  
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APPENDICES 
Appendix A – List of Primer Probes used in this Thesis 
Anti-Oxidant Genes 
hSOD1-F:CTCACTCTCAGGAGACCATTGC 
hSOD1-R: CCACAAGCCAAACGACTTCCAG 
 
hSOD2-F: CTGGACAAACCTCAGCCCTAAC 
hSOD2-R: AACCTGAGCCTTGGACACCAAC 
 
hPPARGC1A(PGC-1a)-F: CCAAAGGATGCGCTCTCGTTCA 
hPPARGC1A(PGC-1a)-R: CGGTGTCTGTAGTGGCTTGACT 
 
hCAT-F: GTGCGGAGATTCAACACTGCCA 
hCAT-R: CGGCAATGTTCTCACACAGACG 
 
hPRDX5-F: TGATGCCTTTGTGACTGGCGAG 
hPRDX5-R: CCAAAGATGGACACCAGCGAATC 
Sirtuins 
hSirt1-F: TAGACACGCTGGAACAGGTTGC 
hSirt1-R: CTCCTCGTACAGCTTCACAGTC 
 
hSirt2-F: CTGCGGAACTTATTCTCCCAGAC 
hSirt2-R: CCACCAAACAGATGACTCTGCG 
 
hSirt3-F: CCCTGGAAACTACAAGCCCAAC 
hSirt3-R: GCAGAGGCAAAGGTTCCATGAG 
 
hSirt4-F: GTGGATGCTTTGCACACCAAGG 
hSirt4-R: GGTTCAGGACTTGGAAACGCTC 
 
hSirt5-F: GTCCACACGAAACCAGATTTGCC 
hSirt5-R: TCCTCTGAAGGTCGGAACACCA 
 
hSirt6-F: TGGCAGTCTTCCAGTGTGGTGT 
hSirt6-R: CGCTCTCAAAGGTGGTGTCGAA 
 
hSirt7-F: TGGAGTGTGGACACTGCTTCAG 
hSirt7-R: CCGTCACAGTTCTGAGACACCA  
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